{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T17:59:39Z","timestamp":1775757579270,"version":"3.50.1"},"publisher-location":"Berlin, Heidelberg","reference-count":248,"publisher":"Springer Berlin Heidelberg","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1007\/82_2025_297","type":"book-chapter","created":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T15:44:47Z","timestamp":1747842287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Innate Immune Recognition of EBV"],"prefix":"10.1007","author":[{"given":"Jessica","family":"Stewart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blossom","family":"Damania","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,22]]},"reference":[{"issue":"7","key":"297_CR1","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1038\/nri2124","volume":"7","author":"S Ahmad","year":"2007","unstructured":"Ahmad S (2007) Turning on TLR9. Nat Rev Immunol 7(7):496\u2013496. https:\/\/doi.org\/10.1038\/nri2124","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"297_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0099163","volume":"9","author":"W Ahmed","year":"2014","unstructured":"Ahmed W, Philip PS, Tariq S, Khan G (2014) Epstein-Barr virus-encoded small RNAs (EBERs) are present in fractions related to exosomes released by EBV-transformed cells. PLoS One 9(6):e99163. https:\/\/doi.org\/10.1371\/journal.pone.0099163","journal-title":"PLoS One"},{"issue":"1","key":"297_CR3","doi-asserted-by":"publisher","first-page":"15438","DOI":"10.1038\/s41598-018-33758-4","volume":"8","author":"W Ahmed","year":"2018","unstructured":"Ahmed W, Tariq S, Khan G (2018) Tracking EBV-encoded RNAs (EBERs) from the nucleus to the excreted exosomes of B-lymphocytes. Sci Rep 8(1):15438. https:\/\/doi.org\/10.1038\/s41598-018-33758-4","journal-title":"Sci Rep"},{"issue":"9","key":"297_CR4","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.4049\/jimmunol.1003615","volume":"186","author":"LL Allan","year":"2011","unstructured":"Allan LL, Stax AM, Zheng DJ, Chung BK, Kozak FK, Tan R, van den Elzen P (2011) CD1d and CD1c expression in human B cells is regulated by activation and retinoic acid receptor signaling. J Immunol 186(9):5261\u20135272. https:\/\/doi.org\/10.4049\/jimmunol.1003615","journal-title":"J Immunol"},{"issue":"15","key":"297_CR5","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1128\/jvi.00805-13","volume":"87","author":"MA Ansari","year":"2013","unstructured":"Ansari MA, Singh VV, Dutta S, Veettil MV, Dutta D, Chikoti L et al (2013) Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells. J Virol 87(15):8606\u20138623. https:\/\/doi.org\/10.1128\/jvi.00805-13","journal-title":"J Virol"},{"issue":"2","key":"297_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1200\/op.20.01020","volume":"17","author":"SM Ansell","year":"2021","unstructured":"Ansell SM (2021) PD-1 blockade in classic hodgkin lymphoma. JCO Oncol Pract 17(2):72\u201373. https:\/\/doi.org\/10.1200\/op.20.01020","journal-title":"JCO Oncol Pract"},{"issue":"4","key":"297_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1411087","volume":"372","author":"SM Ansell","year":"2015","unstructured":"Ansell SM, Lesokhin AM, Borrello I, Halwani A, Scott EC, Gutierrez M et al (2015) PD-1 blockade with nivolumab in relapsed or refractory Hodgkin\u2019s lymphoma. N Engl J Med 372(4):311\u2013319. https:\/\/doi.org\/10.1056\/NEJMoa1411087","journal-title":"N Engl J Med"},{"issue":"3","key":"297_CR8","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1128\/jvi.01369-08","volume":"83","author":"S Apcher","year":"2009","unstructured":"Apcher S, Komarova A, Daskalogianni C, Yin Y, Malbert-Colas L, F\u00e5hraeus R (2009) mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1. J Virol 83(3):1289\u20131298. https:\/\/doi.org\/10.1128\/jvi.01369-08","journal-title":"J Virol"},{"issue":"2","key":"297_CR9","doi-asserted-by":"publisher","first-page":"851","DOI":"10.4049\/jimmunol.182.2.851","volume":"182","author":"ME Ariza","year":"2009","unstructured":"Ariza ME, Glaser R, Kaumaya PT, Jones C, Williams MV (2009) The EBV-encoded dUTPase activates NF-kappa B through the TLR2 and MyD88-dependent signaling pathway. J Immunol 182(2):851\u2013859. https:\/\/doi.org\/10.4049\/jimmunol.182.2.851","journal-title":"J Immunol"},{"issue":"7","key":"297_CR10","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0069827","volume":"8","author":"ME Ariza","year":"2013","unstructured":"Ariza ME, Rivailler P, Glaser R, Chen M, Williams MV (2013) Epstein-Barr virus encoded dUTPase containing exosomes modulate innate and adaptive immune responses in human dendritic cells and peripheral blood mononuclear cells. PLoS One 8(7):e69827. https:\/\/doi.org\/10.1371\/journal.pone.0069827","journal-title":"PLoS One"},{"issue":"16","key":"297_CR11","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1182\/blood-2014-01-553024","volume":"124","author":"T Azzi","year":"2014","unstructured":"Azzi T, L\u00fcnemann A, Murer A, Ueda S, B\u00e9ziat V, Malmberg KJ et al (2014) Role for early-differentiated natural killer cells in infectious mononucleosis. Blood 124(16):2533\u20132543. https:\/\/doi.org\/10.1182\/blood-2014-01-553024","journal-title":"Blood"},{"issue":"12","key":"297_CR12","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.3390\/cancers13123034","volume":"13","author":"C Bailly","year":"2021","unstructured":"Bailly C, Thuru X, Quesnel B (2021) Soluble programmed death ligand-1 (sPD-L1): a pool of circulating proteins implicated in health and diseases. Cancers (Basel) 13(12):3034","journal-title":"Cancers (Basel)"},{"issue":"4","key":"297_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/imm.13799","volume":"172","author":"DC Baiu","year":"2024","unstructured":"Baiu DC, Sharma A, Schehr JL, Basu J, Smith KA, Ohashi M et al (2024) Human CD4+ iNKT cell adoptive immunotherapy induces anti-tumour responses against CD1d-negative EBV-driven B lymphoma. Immunology 172(4):627\u2013640. https:\/\/doi.org\/10.1111\/imm.13799","journal-title":"Immunology"},{"issue":"1","key":"297_CR14","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/infdis\/jis646","volume":"207","author":"HH Balfour Jr","year":"2013","unstructured":"Balfour HH Jr, Odumade OA, Schmeling DO, Mullan BD, Ed JA, Knight JA et al (2013) Behavioral, virologic, and immunologic factors associated with acquisition and severity of primary Epstein-Barr virus infection in university students. J Infect Dis 207(1):80\u201388. https:\/\/doi.org\/10.1093\/infdis\/jis646","journal-title":"J Infect Dis"},{"issue":"11","key":"297_CR15","doi-asserted-by":"publisher","first-page":"3040","DOI":"10.1002\/eji.200636483","volume":"37","author":"TA Barr","year":"2007","unstructured":"Barr TA, Brown S, Ryan G, Zhao J, Gray D (2007) TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells. Eur J Immunol 37(11):3040\u20133053. https:\/\/doi.org\/10.1002\/eji.200636483","journal-title":"Eur J Immunol"},{"issue":"12","key":"297_CR16","doi-asserted-by":"publisher","first-page":"2689","DOI":"10.1084\/jem.20101111","volume":"207","author":"CL Baumann","year":"2010","unstructured":"Baumann CL, Aspalter IM, Sharif O, Pichlmair A, Bl\u00fcml S, Grebien F et al (2010) CD14 is a coreceptor of toll-like receptors 7 and 9. J Exp Med 207(12):2689\u20132701. https:\/\/doi.org\/10.1084\/jem.20101111","journal-title":"J Exp Med"},{"issue":"7","key":"297_CR17","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1182\/blood.V86.7.2789.bloodjournal8672789","volume":"86","author":"AD Beaulieu","year":"1995","unstructured":"Beaulieu AD, Paquin R, Gosselin J (1995) Epstein-Barr virus modulates de novo protein synthesis in human neutrophils. Blood 86(7):2789\u20132798","journal-title":"Blood"},{"issue":"2","key":"297_CR18","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1097\/qad.0000000000001680","volume":"32","author":"K Beima-Sofie","year":"2018","unstructured":"Beima-Sofie K, Wamalwa D, Maleche-Obimbo E, Lingappa JR, Mackelprang R, Gantt S et al (2018) Toll-like receptor 9 polymorphism is associated with increased Epstein-Barr virus and Cytomegalovirus acquisition in HIV-exposed infants. AIDS 32(2):267\u2013270. https:\/\/doi.org\/10.1097\/qad.0000000000001680","journal-title":"AIDS"},{"issue":"1","key":"297_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13045-016-0341-7","volume":"9","author":"XW Bi","year":"2016","unstructured":"Bi XW, Wang H, Zhang WW, Wang JH, Liu WJ, Xia ZJ et al (2016) PD-L1 is upregulated by EBV-driven LMP1 through NF-\u03baB pathway and correlates with poor prognosis in natural killer\/T-cell lymphoma. J Hematol Oncol 9(1):109. https:\/\/doi.org\/10.1186\/s13045-016-0341-7","journal-title":"J Hematol Oncol"},{"issue":"5","key":"297_CR20","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1084\/jem.176.5.1405","volume":"176","author":"M Birkenbach","year":"1992","unstructured":"Birkenbach M, Tong X, Bradbury LE, Tedder TF, Kieff E (1992) Characterization of an Epstein-Barr virus receptor on human epithelial cells. J Exp Med 176(5):1405\u20131414. https:\/\/doi.org\/10.1084\/jem.176.5.1405","journal-title":"J Exp Med"},{"issue":"6","key":"297_CR21","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1038\/nm0602-594","volume":"8","author":"CM Borza","year":"2002","unstructured":"Borza CM, Hutt-Fletcher LM (2002) Alternate replication in B cells and epithelial cells switches tropism of Epstein-Barr virus. Nat Med 8(6):594\u2013599. https:\/\/doi.org\/10.1038\/nm0602-594","journal-title":"Nat Med"},{"issue":"1","key":"297_CR22","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1038\/s41467-023-35898-2","volume":"14","author":"G Broussard","year":"2023","unstructured":"Broussard G, Ni G, Zhang Z, Li Q, Cano P, Dittmer DP, Damania B (2023) Barrier-to-autointegration factor 1 promotes gammaherpesvirus reactivation from latency. Nat Commun 14(1):434. https:\/\/doi.org\/10.1038\/s41467-023-35898-2","journal-title":"Nat Commun"},{"issue":"15","key":"297_CR23","doi-asserted-by":"publisher","first-page":"8532","DOI":"10.1128\/jvi.77.15.8532-8540.2003","volume":"77","author":"HJ Brown","year":"2003","unstructured":"Brown HJ, Song MJ, Deng H, Wu TT, Cheng G, Sun R (2003) NF-kappaB inhibits gammaherpesvirus lytic replication. J Virol 77(15):8532\u20138540. https:\/\/doi.org\/10.1128\/jvi.77.15.8532-8540.2003","journal-title":"J Virol"},{"key":"297_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.oraloncology.2021.105279","volume":"117","author":"A Burassakarn","year":"2021","unstructured":"Burassakarn A, Srisathaporn S, Pientong C, Wongjampa W, Vatanasapt P, Patarapadungkit N, Ekalaksananan T (2021) Exosomes-carrying Epstein-Barr virus-encoded small RNA-1 induces indoleamine 2, 3-dioxygenase expression in tumor-infiltrating macrophages of oral squamous-cell carcinomas and suppresses T-cell activity by activating RIG-I\/IL-6\/TNF-\u03b1 pathway. Oral Oncol 117:105279. https:\/\/doi.org\/10.1016\/j.oraloncology.2021.105279","journal-title":"Oral Oncol"},{"issue":"3","key":"297_CR25","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1073\/pnas.1919133117","volume":"117","author":"EM Burton","year":"2020","unstructured":"Burton EM, Goldbach-Mansky R, Bhaduri-McIntosh S (2020) A promiscuous inflammasome sparks replication of a common tumor virus. Proc Natl Acad Sci USA 117(3):1722\u20131730. https:\/\/doi.org\/10.1073\/pnas.1919133117","journal-title":"Proc Natl Acad Sci USA"},{"issue":"11","key":"297_CR26","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1158\/1055-9965.Epi-05-0229","volume":"14","author":"M Butsch Kovacic","year":"2005","unstructured":"Butsch Kovacic M, Martin M, Gao X, Fuksenko T, Chen C-J, Cheng Y-J et al (2005) Variation of the killer cell immunoglobulin-like receptors and HLA-C genes in nasopharyngeal carcinoma. Cancer Epidemiol Biomarkers Prev 14(11):2673\u20132677. https:\/\/doi.org\/10.1158\/1055-9965.Epi-05-0229","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"7","key":"297_CR27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006503","volume":"13","author":"TT Cai","year":"2017","unstructured":"Cai TT, Ye SB, Liu YN, He J, Chen QY, Mai HQ et al (2017) LMP1-mediated glycolysis induces myeloid-derived suppressor cell expansion in nasopharyngeal carcinoma. PLoS Pathog 13(7):e1006503. https:\/\/doi.org\/10.1371\/journal.ppat.1006503","journal-title":"PLoS Pathog"},{"key":"297_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.991069","volume":"12","author":"K Cai","year":"2022","unstructured":"Cai K, Zhou B, Huang H, Tao R, Sun J, Yan C et al (2022) Risk of malignancy following exposure to Epstein-Barr Virus associated infectious mononucleosis: a nationwide population-based cohort study. Front Oncol 12:991069. https:\/\/doi.org\/10.3389\/fonc.2022.991069","journal-title":"Front Oncol"},{"issue":"12","key":"297_CR29","doi-asserted-by":"publisher","first-page":"7010","DOI":"10.1128\/iai.68.12.7010-7017.2000","volume":"68","author":"E Cario","year":"2000","unstructured":"Cario E, Podolsky DK (2000) Differential alteration in intestinal epithelial cell expression of toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect Immun 68(12):7010\u20137017. https:\/\/doi.org\/10.1128\/iai.68.12.7010-7017.2000","journal-title":"Infect Immun"},{"issue":"2","key":"297_CR30","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/gene.2011.59","volume":"13","author":"A Carvalho","year":"2012","unstructured":"Carvalho A, Cunha C, Almeida AJ, Os\u00f3rio NS, Saraiva M, Teixeira-Coelho M et al (2012) The rs5743836 polymorphism in TLR9 confers a population-based increased risk of non-Hodgkin lymphoma. Genes Immun 13(2):197\u2013201. https:\/\/doi.org\/10.1038\/gene.2011.59","journal-title":"Genes Immun"},{"issue":"10","key":"297_CR31","doi-asserted-by":"publisher","first-page":"4761","DOI":"10.4049\/jimmunol.1401805","volume":"193","author":"MS Chaudhry","year":"2014","unstructured":"Chaudhry MS, Karadimitris A (2014) Role and regulation of CD1d in normal and pathological B cells. J Immunol 193(10):4761\u20134768. https:\/\/doi.org\/10.4049\/jimmunol.1401805","journal-title":"J Immunol"},{"issue":"6","key":"297_CR32","doi-asserted-by":"publisher","first-page":"e008375","DOI":"10.1136\/jitc-2023-008375","volume":"12","author":"Y Chen","year":"2024","unstructured":"Chen Y, Ouyang D, Wang Y, Pan Q, Zhao J, Chen H et al (2024) EBV promotes TCR-T-cell therapy resistance by inducing CD163+M2 macrophage polarization and MMP9 secretion. J Immunother Cancer 12(6):e008375. https:\/\/doi.org\/10.1136\/jitc-2023-008375","journal-title":"J Immunother Cancer"},{"issue":"6","key":"297_CR33","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1016\/j.bbadis.2019.01.015","volume":"1865","author":"S Cheng","year":"2019","unstructured":"Cheng S, Li Z, He J, Fu S, Duan Y, Zhou Q et al (2019) Epstein-Barr virus noncoding RNAs from the extracellular vesicles of nasopharyngeal carcinoma (NPC) cells promote angiogenesis via TLR3\/RIG-I-mediated VCAM-1 expression. Biochim Biophys Acta Mol Basis Dis 1865(6):1201\u20131213. https:\/\/doi.org\/10.1016\/j.bbadis.2019.01.015","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"12","key":"297_CR34","doi-asserted-by":"publisher","first-page":"3243","DOI":"10.1002\/j.1460-2075.1986.tb04635.x","volume":"5","author":"A Chevallier-Greco","year":"1986","unstructured":"Chevallier-Greco A, Manet E, Chavrier P, Mosnier C, Daillie J, Sergeant A (1986) Both Epstein-Barr virus (EBV)-encoded trans-acting factors, EB1 and EB2, are required to activate transcription from an EBV early promoter. EMBO J 5(12):3243\u20133249. https:\/\/doi.org\/10.1002\/j.1460-2075.1986.tb04635.x","journal-title":"EMBO J"},{"issue":"1","key":"297_CR35","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41590-017-0005-y","volume":"19","author":"JJ Chiang","year":"2018","unstructured":"Chiang JJ, Sparrer KMJ, van Gent M, L\u00e4ssig C, Huang T, Osterrieder N et al (2018) Viral unmasking of cellular 5S rRNA pseudogene transcripts induces RIG-I-mediated immunity. Nat Immunol 19(1):53\u201362. https:\/\/doi.org\/10.1038\/s41590-017-0005-y","journal-title":"Nat Immunol"},{"issue":"6","key":"297_CR36","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1016\/j.celrep.2013.11.041","volume":"5","author":"O Chijioke","year":"2013","unstructured":"Chijioke O, M\u00fcller A, Feederle R, Barros MH, Krieg C, Emmel V et al (2013) Human natural killer cells prevent infectious mononucleosis features by targeting lytic Epstein-Barr virus infection. Cell Rep 5(6):1489\u20131498. https:\/\/doi.org\/10.1016\/j.celrep.2013.11.041","journal-title":"Cell Rep"},{"key":"297_CR37","doi-asserted-by":"publisher","unstructured":"Choi SJ, Ryu E, Lee S, Huh S, Shin YS, Kang BW et al (2019) Adenosine induces EBV lytic reactivation through ADORA1 in EBV-associated gastric carcinoma. Int J Mol Sci 20(6). https:\/\/doi.org\/10.3390\/ijms20061286","DOI":"10.3390\/ijms20061286"},{"issue":"15","key":"297_CR38","doi-asserted-by":"publisher","first-page":"2600","DOI":"10.1182\/blood-2013-01-480665","volume":"122","author":"BK Chung","year":"2013","unstructured":"Chung BK, Tsai K, Allan LL, Zheng DJ, Nie JC, Biggs CM et al (2013) Innate immune control of EBV-infected B cells by invariant natural killer T cells. Blood 122(15):2600\u20132608. https:\/\/doi.org\/10.1182\/blood-2013-01-480665","journal-title":"Blood"},{"issue":"2","key":"297_CR39","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1182\/blood.2020005611","volume":"137","author":"PJ Collins","year":"2021","unstructured":"Collins PJ, Fox CP, George L, Pearce H, Ryan G, De Santo C et al (2021) Characterizing EBV-associated lymphoproliferative diseases and the role of myeloid-derived suppressor cells. Blood 137(2):203\u2013215. https:\/\/doi.org\/10.1182\/blood.2020005611","journal-title":"Blood"},{"issue":"11","key":"297_CR40","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/s1471-4906(01)02060-9","volume":"22","author":"MA Cooper","year":"2001","unstructured":"Cooper MA, Fehniger TA, Caligiuri MA (2001) The biology of human natural killer-cell subsets. Trends Immunol 22(11):633\u2013640. https:\/\/doi.org\/10.1016\/s1471-4906(01)02060-9","journal-title":"Trends Immunol"},{"issue":"20","key":"297_CR41","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","volume":"185","author":"B Damania","year":"2022","unstructured":"Damania B, Kenney SC, Raab-Traub N (2022) Epstein-Barr virus: biology and clinical disease. Cell 185(20):3652\u20133670. https:\/\/doi.org\/10.1016\/j.cell.2022.08.026","journal-title":"Cell"},{"key":"297_CR42","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13027-020-00307-6","volume":"15","author":"V De Re","year":"2020","unstructured":"De Re V, Caggiari L, De Zorzi M, Fanotto V, Miolo G, Puglisi F et al (2020) Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer. Infect Agent Cancer 15:42. https:\/\/doi.org\/10.1186\/s13027-020-00307-6","journal-title":"Infect Agent Cancer"},{"key":"297_CR43","doi-asserted-by":"publisher","unstructured":"Dias JM, Santana IVV, da Silva VD, Carvalho AL, Arantes L (2022) Analysis of Epstein-Barr Virus (EBV) and PD-L1 expression in nasopharyngeal carcinoma patients in a non-endemic region. Int J Mol Sci 23(19). https:\/\/doi.org\/10.3390\/ijms231911720","DOI":"10.3390\/ijms231911720"},{"issue":"51","key":"297_CR44","doi-asserted-by":"publisher","first-page":"36953","DOI":"10.1074\/jbc.M707682200","volume":"282","author":"SL Doyle","year":"2007","unstructured":"Doyle SL, Jefferies CA, Feighery C, O\u2019Neill LA (2007) Signaling by toll-like receptors 8 and 9 requires Bruton\u2019s tyrosine kinase. J Biol Chem 282(51):36953\u201336960. https:\/\/doi.org\/10.1074\/jbc.M707682200","journal-title":"J Biol Chem"},{"issue":"3","key":"297_CR45","first-page":"362","volume":"11","author":"X Du","year":"2000","unstructured":"Du X, Poltorak A, Wei Y, Beutler B (2000) Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur Cytokine Netw 11(3):362\u2013371","journal-title":"Eur Cytokine Netw"},{"issue":"1","key":"297_CR46","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.canlet.2015.02.037","volume":"361","author":"Y Duan","year":"2015","unstructured":"Duan Y, Li Z, Cheng S, Chen Y, Zhang L, He J et al (2015) Nasopharyngeal carcinoma progression is mediated by EBER-triggered inflammation via the RIG-I pathway. Cancer Lett 361(1):67\u201374. https:\/\/doi.org\/10.1016\/j.canlet.2015.02.037","journal-title":"Cancer Lett"},{"issue":"6","key":"297_CR47","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1158\/0008-5472.Can-21-2292","volume":"82","author":"X Duan","year":"2022","unstructured":"Duan X, Chen H, Zhou X, Liu P, Zhang X, Zhu Q et al (2022a) EBV infection in epithelial malignancies induces resistance to antitumor natural killer cells via F3-mediated platelet aggregation. Cancer Res 82(6):1070\u20131083. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-2292","journal-title":"Cancer Res"},{"key":"297_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.812774","volume":"13","author":"T Duan","year":"2022","unstructured":"Duan T, Du Y, Xing C, Wang HY, Wang RF (2022b) Toll-like receptor signaling and its role in cell-mediated immunity. Front Immunol 13:812774. https:\/\/doi.org\/10.3389\/fimmu.2022.812774","journal-title":"Front Immunol"},{"key":"297_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109238","volume":"247","author":"Y Duan","year":"2023","unstructured":"Duan Y, Li S, Huang B, Dou Y, Kong P, Kang W, Xu D (2023) CD47-targeted immunotherapy unleashes antitumour immunity in Epstein-Barr virus-associated gastric cancer. Clin Immunol 247:109238. https:\/\/doi.org\/10.1016\/j.clim.2023.109238","journal-title":"Clin Immunol"},{"issue":"4","key":"297_CR50","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/eji.200323797","volume":"33","author":"AD Edwards","year":"2003","unstructured":"Edwards AD, Diebold SS, Slack EMC, Tomizawa H, Hemmi H, Kaisho T et al (2003) Toll-like receptor expression in murine DC subsets: lack of TLR7 expression by CD8\u03b1+ DC correlates with unresponsiveness to imidazoquinolines. Eur J Immunol 33(4):827\u2013833. https:\/\/doi.org\/10.1002\/eji.200323797","journal-title":"Eur J Immunol"},{"issue":"23","key":"297_CR51","doi-asserted-by":"publisher","first-page":"12189","DOI":"10.18632\/oncotarget.2608","volume":"5","author":"W Fang","year":"2014","unstructured":"Fang W, Zhang J, Hong S, Zhan J, Chen N, Qin T et al (2014) ebv-driven lmp1 and ifn-\u03b3 up-regulate pd-l1 in nasopharyngeal carcinoma: implications for oncotargeted therapy. Oncotarget 5(23):12189\u201312202. https:\/\/doi.org\/10.18632\/oncotarget.2608","journal-title":"Oncotarget"},{"issue":"10","key":"297_CR52","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1016\/S1470-2045(18)30495-9","volume":"19","author":"W Fang","year":"2018","unstructured":"Fang W, Yang Y, Ma Y, Hong S, Lin L, He X et al (2018) Camrelizumab (SHR-1210) alone or in combination with gemcitabine plus cisplatin for nasopharyngeal carcinoma: results from two single-arm, phase 1 trials. Lancet Oncol 19(10):1338\u20131350. https:\/\/doi.org\/10.1016\/S1470-2045(18)30495-9","journal-title":"Lancet Oncol"},{"issue":"1","key":"297_CR53","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13075-017-1237-9","volume":"19","author":"A Farina","year":"2017","unstructured":"Farina A, Peruzzi G, Lacconi V, Lenna S, Quarta S, Rosato E et al (2017) Epstein-Barr virus lytic infection promotes activation of toll-like receptor 8 innate immune response in systemic sclerosis monocytes. Arthritis Res Ther 19(1):39. https:\/\/doi.org\/10.1186\/s13075-017-1237-9","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"297_CR54","doi-asserted-by":"publisher","first-page":"6439","DOI":"10.4049\/jimmunol.0903459","volume":"185","author":"I Fathallah","year":"2010","unstructured":"Fathallah I, Parroche P, Gruffat H, Zannetti C, Johansson H, Yue J et al (2010) EBV latent membrane protein 1 is a negative regulator of TLR9. J Immunol 185(11):6439\u20136447. https:\/\/doi.org\/10.4049\/jimmunol.0903459","journal-title":"J Immunol"},{"issue":"12","key":"297_CR55","doi-asserted-by":"publisher","first-page":"3080","DOI":"10.1093\/emboj\/19.12.3080","volume":"19","author":"R Feederle","year":"2000","unstructured":"Feederle R, Kost M, Baumann M, Janz A, Drouet E, Hammerschmidt W, Delecluse HJ (2000) The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators. EMBO J 19(12):3080\u20133089. https:\/\/doi.org\/10.1093\/emboj\/19.12.3080","journal-title":"EMBO J"},{"issue":"45","key":"297_CR56","doi-asserted-by":"publisher","first-page":"33871","DOI":"10.1074\/jbc.M600468200","volume":"281","author":"ZA Felton-Edkins","year":"2006","unstructured":"Felton-Edkins ZA, Kondrashov A, Karali D, Fairley JA, Dawson CW, Arrand JR et al (2006) Epstein-Barr Virus induces cellular transcription factors to allow active expression of EBER Genes by RNA Polymerase III *. J Biol Chem 281(45):33871\u201333880. https:\/\/doi.org\/10.1074\/jbc.M600468200","journal-title":"J Biol Chem"},{"issue":"14","key":"297_CR57","doi-asserted-by":"publisher","first-page":"4510","DOI":"10.1073\/pnas.81.14.4510","volume":"81","author":"JD Fingeroth","year":"1984","unstructured":"Fingeroth JD, Weis JJ, Tedder TF, Strominger JL, Biro PA, Fearon DT (1984) Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. Proc Natl Acad Sci USA 81(14):4510\u20134514. https:\/\/doi.org\/10.1073\/pnas.81.14.4510","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"297_CR58","doi-asserted-by":"publisher","first-page":"3620","DOI":"10.4049\/jimmunol.0903736","volume":"185","author":"S Fiola","year":"2010","unstructured":"Fiola S, Gosselin D, Takada K, Gosselin J (2010) TLR9 contributes to the recognition of EBV by primary monocytes and plasmacytoid dendritic cells. J Immunol 185(6):3620\u20133631. https:\/\/doi.org\/10.4049\/jimmunol.0903736","journal-title":"J Immunol"},{"issue":"6","key":"297_CR59","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","volume":"180","author":"KA Fitzgerald","year":"2020","unstructured":"Fitzgerald KA, Kagan JC (2020) Toll-like receptors and the control of immunity. Cell 180(6):1044\u20131066. https:\/\/doi.org\/10.1016\/j.cell.2020.02.041","journal-title":"Cell"},{"issue":"12","key":"297_CR60","doi-asserted-by":"publisher","first-page":"7073","DOI":"10.1128\/jvi.65.12.7073-7077.1991","volume":"65","author":"EK Flemington","year":"1991","unstructured":"Flemington EK, Goldfeld AE, Speck SH (1991) Efficient transcription of the Epstein-Barr virus immediate-early BZLF1 and BRLF1 genes requires protein synthesis. J Virol 65(12):7073\u20137077. https:\/\/doi.org\/10.1128\/jvi.65.12.7073-7077.1991","journal-title":"J Virol"},{"issue":"3","key":"297_CR61","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1182\/blood.V83.3.707.707","volume":"83","author":"HD Foss","year":"1994","unstructured":"Foss HD, Herbst H, Hummel M, Araujo I, Latza U, Rancs\u00f2 C et al (1994) Patterns of cytokine gene expression in infectious mononucleosis. Blood 83(3):707\u2013712","journal-title":"Blood"},{"issue":"3","key":"297_CR62","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1038\/s41375-022-01804-w","volume":"37","author":"F Frontzek","year":"2023","unstructured":"Frontzek F, Staiger AM, Wullenkord R, Grau M, Zapukhlyak M, Kurz KS et al (2023) Molecular profiling of EBV associated diffuse large B-cell lymphoma. Leukemia 37(3):670\u2013679. https:\/\/doi.org\/10.1038\/s41375-022-01804-w","journal-title":"Leukemia"},{"issue":"1","key":"297_CR63","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s12985-021-01678-x","volume":"18","author":"MM Gaglia","year":"2021","unstructured":"Gaglia MM (2021) Anti-viral and pro-inflammatory functions of toll-like receptors during gamma-herpesvirus infections. Virol J 18(1):218. https:\/\/doi.org\/10.1186\/s12985-021-01678-x","journal-title":"Virol J"},{"issue":"15","key":"297_CR64","doi-asserted-by":"publisher","first-page":"8016","DOI":"10.1128\/jvi.00403-07","volume":"81","author":"E Gaudreault","year":"2007","unstructured":"Gaudreault E, Fiola S, Olivier M, Gosselin J (2007) Epstein-Barr virus induces MCP-1 secretion by human monocytes via TLR2. J Virol 81(15):8016\u20138024. https:\/\/doi.org\/10.1128\/jvi.00403-07","journal-title":"J Virol"},{"issue":"19","key":"297_CR65","doi-asserted-by":"publisher","first-page":"5074","DOI":"10.1158\/0008-5472.Can-20-4321","volume":"81","author":"J Ge","year":"2021","unstructured":"Ge J, Wang J, Xiong F, Jiang X, Zhu K, Wang Y et al (2021) Epstein-Barr virus-encoded circular RNA CircBART2.2 promotes immune escape of nasopharyngeal carcinoma by regulating PD-L1. Cancer Res 81(19):5074\u20135088. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-4321","journal-title":"Cancer Res"},{"issue":"4","key":"297_CR66","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1080\/15548627.2018.1536530","volume":"15","author":"MS Gilardini Montani","year":"2019","unstructured":"Gilardini Montani MS, Santarelli R, Granato M, Gonnella R, Torrisi MR, Faggioni A, Cirone M (2019) EBV reduces autophagy, intracellular ROS and mitochondria to impair monocyte survival and differentiation. Autophagy 15(4):652\u2013667. https:\/\/doi.org\/10.1080\/15548627.2018.1536530","journal-title":"Autophagy"},{"issue":"3","key":"297_CR67","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1128\/jvi.62.3.902-911.1988","volume":"62","author":"JN Glickman","year":"1988","unstructured":"Glickman JN, Howe JG, Steitz JA (1988) Structural analyses of EBER1 and EBER2 ribonucleoprotein particles present in Epstein-Barr virus-infected cells. J Virol 62(3):902\u2013911. https:\/\/doi.org\/10.1128\/jvi.62.3.902-911.1988","journal-title":"J Virol"},{"key":"297_CR68","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.molimm.2017.08.025","volume":"91","author":"AM Gram","year":"2017","unstructured":"Gram AM, Sun C, Landman SL, Oosenbrug T, Koppejan HJ, Kwakkenbos MJ et al (2017) Human B cells fail to secrete type I interferons upon cytoplasmic DNA exposure. Mol Immunol 91:225\u2013237. https:\/\/doi.org\/10.1016\/j.molimm.2017.08.025","journal-title":"Mol Immunol"},{"key":"297_CR69","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s13027-020-00292-w","volume":"15","author":"M Granai","year":"2020","unstructured":"Granai M, Mundo L, Akarca AU, Siciliano MC, Rizvi H, Mancini V et al (2020) Immune landscape in Burkitt lymphoma reveals M2-macrophage polarization and correlation between PD-L1 expression and non-canonical EBV latency program. Infect Agent Cancer 15:28. https:\/\/doi.org\/10.1186\/s13027-020-00292-w","journal-title":"Infect Agent Cancer"},{"issue":"6","key":"297_CR70","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1158\/1078-0432.Ccr-11-1942","volume":"18","author":"MR Green","year":"2012","unstructured":"Green MR, Rodig S, Juszczynski P, Ouyang J, Sinha P, O\u2019Donnell E et al (2012) Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy. Clin Cancer Res 18(6):1611\u20131618. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-11-1942","journal-title":"Clin Cancer Res"},{"issue":"6505","key":"297_CR71","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1126\/science.aaw6421","volume":"369","author":"B Guey","year":"2020","unstructured":"Guey B, Wischnewski M, Decout A, Makasheva K, Kaynak M, Sakar MS et al (2020) BAF restricts cGAS on nuclear DNA to prevent innate immune activation. Science 369(6505):823\u2013828. https:\/\/doi.org\/10.1126\/science.aaw6421","journal-title":"Science"},{"issue":"7","key":"297_CR72","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1182\/bloodadvances.2018025536","volume":"3","author":"C Gujer","year":"2019","unstructured":"Gujer C, Murer A, M\u00fcller A, Vanoaica D, Sutter K, Jacque E et al (2019) Plasmacytoid dendritic cells respond to Epstein-Barr virus infection with a distinct type I interferon subtype profile. Blood Adv 3(7):1129\u20131144. https:\/\/doi.org\/10.1182\/bloodadvances.2018025536","journal-title":"Blood Adv"},{"issue":"1","key":"297_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006852","volume":"14","author":"S Gupta","year":"2018","unstructured":"Gupta S, Yl\u00e4-Anttila P, Callegari S, Tsai MH, Delecluse HJ, Masucci MG (2018) Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome. PLoS Pathog 14(1):e1006852. https:\/\/doi.org\/10.1371\/journal.ppat.1006852","journal-title":"PLoS Pathog"},{"issue":"8","key":"297_CR74","doi-asserted-by":"publisher","first-page":"3795","DOI":"10.4049\/jimmunol.1200312","volume":"189","author":"M Haneklaus","year":"2012","unstructured":"Haneklaus M, Gerlic M, Kurowska-Stolarska M, Rainey AA, Pich D, McInnes IB et al (2012) Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1\u03b2 production. J Immunol 189(8):3795\u20133799. https:\/\/doi.org\/10.4049\/jimmunol.1200312","journal-title":"J Immunol"},{"issue":"5","key":"297_CR75","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1038\/sj.bjp.0703134","volume":"129","author":"G Hask\u00f3","year":"2000","unstructured":"Hask\u00f3 G, Kuhel DG, Salzman AL, Szab\u00f3 C (2000) ATP suppression of interleukin-12 and tumour necrosis factor-alpha release from macrophages. Br J Pharmacol 129(5):909\u2013914. https:\/\/doi.org\/10.1038\/sj.bjp.0703134","journal-title":"Br J Pharmacol"},{"issue":"7","key":"297_CR76","doi-asserted-by":"publisher","first-page":"4479","DOI":"10.4049\/jimmunol.173.7.4479","volume":"173","author":"B He","year":"2004","unstructured":"He B, Qiao X, Cerutti A (2004) CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol 173(7):4479\u20134491. https:\/\/doi.org\/10.4049\/jimmunol.173.7.4479","journal-title":"J Immunol"},{"issue":"23","key":"297_CR77","doi-asserted-by":"publisher","first-page":"2562","DOI":"10.1016\/j.vaccine.2016.04.012","volume":"34","author":"DS Heeke","year":"2016","unstructured":"Heeke DS, Lin R, Rao E, Woo JC, McCarthy MP, Marshall JD (2016) Identification of GLA\/SE as an effective adjuvant for the induction of robust humoral and cell-mediated immune responses to EBV-gp350 in mice and rabbits. Vaccine 34(23):2562\u20132569. https:\/\/doi.org\/10.1016\/j.vaccine.2016.04.012","journal-title":"Vaccine"},{"issue":"9","key":"297_CR78","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/s41580-020-0244-x","volume":"21","author":"K-P Hopfner","year":"2020","unstructured":"Hopfner K-P, Hornung V (2020) Molecular mechanisms and cellular functions of cGAS\u2013STING signalling. Nat Rev Mol Cell Biol 21(9):501\u2013521. https:\/\/doi.org\/10.1038\/s41580-020-0244-x","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"297_CR79","doi-asserted-by":"publisher","first-page":"4531","DOI":"10.4049\/jimmunol.168.9.4531","volume":"168","author":"V Hornung","year":"2002","unstructured":"Hornung V, Rothenfusser S, Britsch S, Krug A, Jahrsd\u00f6rfer B, Giese T et al (2002) Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol 168(9):4531\u20134537. https:\/\/doi.org\/10.4049\/jimmunol.168.9.4531","journal-title":"J Immunol"},{"key":"297_CR80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.587380","volume":"11","author":"G Houen","year":"2020","unstructured":"Houen G, Trier NH (2020) Epstein-Barr Virus and systemic autoimmune diseases. Front Immunol 11:587380. https:\/\/doi.org\/10.3389\/fimmu.2020.587380","journal-title":"Front Immunol"},{"issue":"8","key":"297_CR81","doi-asserted-by":"publisher","first-page":"2790","DOI":"10.1128\/jvi.62.8.2790-2798.1988","volume":"62","author":"JG Howe","year":"1988","unstructured":"Howe JG, Shu MD (1988) Isolation and characterization of the genes for two small RNAs of herpesvirus papio and their comparison with Epstein-Barr virus-encoded EBER RNAs. J Virol 62(8):2790\u20132798. https:\/\/doi.org\/10.1128\/jvi.62.8.2790-2798.1988","journal-title":"J Virol"},{"issue":"36","key":"297_CR82","doi-asserted-by":"publisher","first-page":"4050","DOI":"10.1200\/jco.2017.73.3675","volume":"35","author":"C Hsu","year":"2017","unstructured":"Hsu C, Lee S-H, Ejadi S, Even C, Cohen RB, Tourneau CL et al (2017) Safety and antitumor activity of pembrolizumab in patients with programmed death-ligand 1\u2013positive nasopharyngeal carcinoma: results of the KEYNOTE-028 study. J Clin Oncol 35(36):4050\u20134056. https:\/\/doi.org\/10.1200\/jco.2017.73.3675","journal-title":"J Clin Oncol"},{"issue":"8","key":"297_CR83","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1086\/656335","volume":"202","author":"M Hug","year":"2010","unstructured":"Hug M, Dorner M, Fr\u00f6hlich FZ, Gysin C, Neuhaus D, Nadal D, Berger C (2010) Pediatric epstein-barr virus carriers with or without tonsillar enlargement may substantially contribute to spreading of the virus. J Infect Dis 202(8):1192\u20131199. https:\/\/doi.org\/10.1086\/656335","journal-title":"J Infect Dis"},{"key":"297_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2020.575255","volume":"11","author":"T Inagaki","year":"2020","unstructured":"Inagaki T, Sato Y, Ito J, Takaki M, Okuno Y, Yaguchi M et al (2020) Direct evidence of abortive lytic infection-mediated establishment of Epstein-Barr virus latency during B-cell infection. Front Microbiol 11:575255. https:\/\/doi.org\/10.3389\/fmicb.2020.575255","journal-title":"Front Microbiol"},{"key":"297_CR85","doi-asserted-by":"publisher","unstructured":"Indari O, Ghosh S, Bal AS, James A, Garg M, Mishra A et al (2024) Awakening the sleeping giant: Epstein-Barr virus reactivation by biological agents. Pathog Dis 82. https:\/\/doi.org\/10.1093\/femspd\/ftae002","DOI":"10.1093\/femspd\/ftae002"},{"issue":"10","key":"297_CR86","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1084\/jem.20081761","volume":"206","author":"D Iwakiri","year":"2009","unstructured":"Iwakiri D, Zhou L, Samanta M, Matsumoto M, Ebihara T, Seya T et al (2009) Epstein-Barr virus (EBV)-encoded small RNA is released from EBV-infected cells and activates signaling from toll-like receptor 3. J Exp Med 206(10):2091\u20132099. https:\/\/doi.org\/10.1084\/jem.20081761","journal-title":"J Exp Med"},{"issue":"1","key":"297_CR87","doi-asserted-by":"publisher","first-page":"13154","DOI":"10.1038\/s41598-020-70129-4","volume":"10","author":"A Jab\u0142o\u0144ska","year":"2020","unstructured":"Jab\u0142o\u0144ska A, Studzi\u0144ska M, Szenborn L, Wi\u015bniewska-Ligier M, Karlikowska-Skwarnik M, G\u0119sicki T, Paradowska E (2020) TLR4 896A\/G and TLR9 1174G\/A polymorphisms are associated with the risk of infectious mononucleosis. Sci Rep 10(1):13154. https:\/\/doi.org\/10.1038\/s41598-020-70129-4","journal-title":"Sci Rep"},{"issue":"10","key":"297_CR88","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1002\/1521-4141(2001010)31:10<3121::aid-immu3121>3.0.co;2-4","volume":"31","author":"R Jacobs","year":"2001","unstructured":"Jacobs R, Hintzen G, Kemper A, Beul K, Kempf S, Behrens G et al (2001) CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells. Eur J Immunol 31(10):3121\u20133127. https:\/\/doi.org\/10.1002\/1521-4141(2001010)31:10<3121::aid-immu3121>3.0.co;2-4","journal-title":"Eur J Immunol"},{"issue":"10","key":"297_CR89","doi-asserted-by":"publisher","first-page":"3533","DOI":"10.1073\/pnas.0308496101","volume":"101","author":"Z Jiang","year":"2004","unstructured":"Jiang Z, Mak TW, Sen G, Li X (2004) Toll-like receptor 3-mediated activation of NF-kappaB and IRF3 diverges at Toll-IL-1 receptor domain-containing adapter inducing IFN-beta. Proc Natl Acad Sci USA 101(10):3533\u20133538. https:\/\/doi.org\/10.1073\/pnas.0308496101","journal-title":"Proc Natl Acad Sci USA"},{"key":"297_CR90","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.829943","volume":"13","author":"P Jiang","year":"2022","unstructured":"Jiang P, Nolte IM, Hepkema BG, Stulp M, van den Berg A, Diepstra A (2022) Killer cell immunoglobulin-like receptor haplotype B modulates susceptibility to EBV-associated classic hodgkin lymphoma. Front Immunol 13:829943. https:\/\/doi.org\/10.3389\/fimmu.2022.829943","journal-title":"Front Immunol"},{"issue":"4","key":"297_CR91","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.humimm.2014.02.002","volume":"75","author":"Y-Y Jin","year":"2014","unstructured":"Jin Y-Y, Wang X, Du J, Cao R-M, Law HKW, Wang J-J, Chen T-X (2014) Epstein\u2013Barr virus induces the differentiation of semi-mature dendritic cells from cord blood monocytes. Hum Immunol 75(4):306\u2013316. https:\/\/doi.org\/10.1016\/j.humimm.2014.02.002","journal-title":"Hum Immunol"},{"issue":"11","key":"297_CR92","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41422-020-00402-8","volume":"30","author":"S Jin","year":"2020","unstructured":"Jin S, Li R, Chen M-Y, Yu C, Tang L-Q, Liu Y-M et al (2020) Single-cell transcriptomic analysis defines the interplay between tumor cells, viral infection, and the microenvironment in nasopharyngeal carcinoma. Cell Res 30(11):950\u2013965. https:\/\/doi.org\/10.1038\/s41422-020-00402-8","journal-title":"Cell Res"},{"issue":"5","key":"297_CR93","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1002704","volume":"8","author":"S Jochum","year":"2012","unstructured":"Jochum S, Moosmann A, Lang S, Hammerschmidt W, Zeidler R (2012) The EBV immunoevasins vIL-10 and BNLF2a protect newly infected B cells from immune recognition and elimination. PLoS Pathog 8(5):e1002704. https:\/\/doi.org\/10.1371\/journal.ppat.1002704","journal-title":"PLoS Pathog"},{"key":"297_CR94","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.3389\/fimmu.2018.02198","volume":"9","author":"NR Jog","year":"2018","unstructured":"Jog NR, Chakravarty EF, Guthridge JM, James JA (2018) Epstein Barr virus interleukin 10 suppresses anti-inflammatory phenotype in human monocytes. Front Immunol 9:2198. https:\/\/doi.org\/10.3389\/fimmu.2018.02198","journal-title":"Front Immunol"},{"issue":"3","key":"297_CR95","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1158\/1078-0432.Ccr-12-2693","volume":"19","author":"K Jones","year":"2013","unstructured":"Jones K, Vari F, Keane C, Crooks P, Nourse JP, Seymour LA et al (2013) Serum CD163 and TARC as disease response biomarkers in classical Hodgkin lymphoma. Clin Cancer Res 19(3):731\u2013742. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-12-2693","journal-title":"Clin Cancer Res"},{"issue":"4","key":"297_CR96","doi-asserted-by":"publisher","first-page":"6130","DOI":"10.18632\/oncotarget.14045","volume":"8","author":"A Jud","year":"2017","unstructured":"Jud A, Kotur M, Berger C, Gysin C, Nadal D, L\u00fcnemann A (2017) Tonsillar CD56brightNKG2A+ NK cells restrict primary Epstein-Barr virus infection in B cells via IFN-\u03b3. Oncotarget 8(4):6130\u20136141. https:\/\/doi.org\/10.18632\/oncotarget.14045","journal-title":"Oncotarget"},{"issue":"18","key":"297_CR97","doi-asserted-by":"publisher","first-page":"6696","DOI":"10.1073\/pnas.0802736105","volume":"105","author":"BK Kaiser","year":"2008","unstructured":"Kaiser BK, Pizarro JC, Kerns J, Strong RK (2008) Structural basis for NKG2A\/CD94 recognition of HLA-E. Proc Natl Acad Sci 105(18):6696\u20136701. https:\/\/doi.org\/10.1073\/pnas.0802736105","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"297_CR98","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.pcl.2019.06.011","volume":"66","author":"BP Kaur","year":"2019","unstructured":"Kaur BP, Secord E (2019) Innate immunity. Pediatr Clin N Am 66(5):905\u2013911. https:\/\/doi.org\/10.1016\/j.pcl.2019.06.011","journal-title":"Pediatr Clin N Am"},{"issue":"3","key":"297_CR99","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/ejh.13274","volume":"103","author":"C Keane","year":"2019","unstructured":"Keane C, Tobin J, Gunawardana J, Francis S, Gifford G, Gabrielli S et al (2019) The tumour microenvironment is immuno-tolerogenic and a principal determinant of patient outcome in EBV-positive diffuse large B-cell lymphoma. Eur J Haematol 103(3):200\u2013207. https:\/\/doi.org\/10.1111\/ejh.13274","journal-title":"Eur J Haematol"},{"issue":"Pt 4","key":"297_CR100","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1099\/0022-1317-65-4-837","volume":"65","author":"H Kikuta","year":"1984","unstructured":"Kikuta H, Mizuno F, Yano S, Osato T (1984) Interferon production by Epstein-Barr virus in human mononuclear leukocytes. J Gen Virol 65(Pt 4):837\u2013841. https:\/\/doi.org\/10.1099\/0022-1317-65-4-837","journal-title":"J Gen Virol"},{"key":"297_CR101","doi-asserted-by":"publisher","first-page":"1342455","DOI":"10.3389\/fimmu.2024.1342455","volume":"15","author":"IY Kong","year":"2024","unstructured":"Kong IY, Giulino-Roth L (2024) Targeting latent viral infection in EBV-associated lymphomas. Front Immunol 15:1342455. https:\/\/doi.org\/10.3389\/fimmu.2024.1342455","journal-title":"Front Immunol"},{"issue":"10","key":"297_CR102","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1097\/pas.0000000000001919","volume":"46","author":"A Kume","year":"2022","unstructured":"Kume A, Shinozaki-Ushiku A, Kunita A, Kondo A, Ushiku T (2022) Enhanced PD-L1 expression in LMP1-positive cells of Epstein-Barr virus-associated malignant lymphomas and lymphoproliferative disorders: a single-cell resolution analysis with multiplex fluorescence immunohistochemistry and in situ hybridization. Am J Surg Pathol 46(10):1386\u20131396. https:\/\/doi.org\/10.1097\/pas.0000000000001919","journal-title":"Am J Surg Pathol"},{"issue":"8","key":"297_CR103","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1111\/j.1462-5822.2007.00937.x","volume":"9","author":"K Ladell","year":"2007","unstructured":"Ladell K, Dorner M, Zauner L, Berger C, Zucol F, Bernasconi M et al (2007) Immune activation suppresses initiation of lytic Epstein-Barr virus infection. Cell Microbiol 9(8):2055\u20132069. https:\/\/doi.org\/10.1111\/j.1462-5822.2007.00937.x","journal-title":"Cell Microbiol"},{"key":"297_CR104","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3389\/fimmu.2020.01231","volume":"11","author":"JKP Lam","year":"2020","unstructured":"Lam JKP, Azzi T, Hui KF, Wong AMG, McHugh D, Caduff N et al (2020) Co-infection of cytomegalovirus and Epstein-Barr Virus diminishes the frequency of CD56(dim)NKG2A(+)KIR(\u2212) NK cells and contributes to suboptimal control of EBV in immunosuppressed children with post-transplant lymphoproliferative disorder. Front Immunol 11:1231. https:\/\/doi.org\/10.3389\/fimmu.2020.01231","journal-title":"Front Immunol"},{"issue":"10","key":"297_CR105","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1172\/jci86923","volume":"126","author":"V Landtwing","year":"2016","unstructured":"Landtwing V, Raykova A, Pezzino G, B\u00e9ziat V, Marcenaro E, Graf C et al (2016) Cognate HLA absence in trans diminishes human NK cell education. J Clin Invest 126(10):3772\u20133782. https:\/\/doi.org\/10.1172\/jci86923","journal-title":"J Clin Invest"},{"issue":"2","key":"297_CR106","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03459-22","volume":"14","author":"PT Lange","year":"2023","unstructured":"Lange PT, Damania B (2023) Epstein-Barr Virus-positive lymphomas exploit ectonucleotidase activity to limit immune responses and prevent cell death. MBio 14(2):e0345922. https:\/\/doi.org\/10.1128\/mbio.03459-22","journal-title":"MBio"},{"issue":"6","key":"297_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmb.2021.167214","volume":"434","author":"PT Lange","year":"2022","unstructured":"Lange PT, White MC, Damania B (2022) Activation and evasion of innate immunity by gammaherpesviruses. J Mol Biol 434(6):167214. https:\/\/doi.org\/10.1016\/j.jmb.2021.167214","journal-title":"J Mol Biol"},{"issue":"23","key":"297_CR108","doi-asserted-by":"publisher","first-page":"12616","DOI":"10.1073\/pnas.94.23.12616","volume":"94","author":"J Levitskaya","year":"1997","unstructured":"Levitskaya J, Sharipo A, Leonchiks A, Ciechanover A, Masucci MG (1997) Inhibition of ubiquitin\/proteasome-dependent protein degradation by the Gly-Ala repeat domain of the Epstein-Barr virus nuclear antigen 1. Proc Natl Acad Sci USA 94(23):12616\u201312621. https:\/\/doi.org\/10.1073\/pnas.94.23.12616","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"297_CR109","doi-asserted-by":"publisher","first-page":"3725","DOI":"10.1182\/blood.v99.10.3725","volume":"99","author":"L Li","year":"2002","unstructured":"Li L, Liu D, Hutt-Fletcher L, Morgan A, Masucci MG, Levitsky V (2002) Epstein-Barr virus inhibits the development of dendritic cells by promoting apoptosis of their monocyte precursors in the presence of granulocyte macrophage-colony-stimulating factor and interleukin-4. Blood 99(10):3725\u20133734. https:\/\/doi.org\/10.1182\/blood.v99.10.3725","journal-title":"Blood"},{"issue":"6152","key":"297_CR110","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1126\/science.1244040","volume":"341","author":"XD Li","year":"2013","unstructured":"Li XD, Wu J, Gao D, Wang H, Sun L, Chen ZJ (2013) Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341(6152):1390\u20131394. https:\/\/doi.org\/10.1126\/science.1244040","journal-title":"Science"},{"issue":"27","key":"297_CR111","doi-asserted-by":"publisher","first-page":"24291","DOI":"10.18632\/oncotarget.4552","volume":"6","author":"Z Li","year":"2015","unstructured":"Li Z, Duan Y, Cheng S, Chen Y, Hu Y, Zhang L et al (2015) EBV-encoded RNA via TLR3 induces inflammation in nasopharyngeal carcinoma. Oncotarget 6(27):24291\u201324303. https:\/\/doi.org\/10.18632\/oncotarget.4552","journal-title":"Oncotarget"},{"issue":"3","key":"297_CR112","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1006249","volume":"13","author":"X Li","year":"2017","unstructured":"Li X, Burton EM, Bhaduri-McIntosh S (2017) Chloroquine triggers Epstein-Barr virus replication through phosphorylation of KAP1\/TRIM28 in Burkitt lymphoma cells. PLoS Pathog 13(3):e1006249. https:\/\/doi.org\/10.1371\/journal.ppat.1006249","journal-title":"PLoS Pathog"},{"issue":"1","key":"297_CR113","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12672-022-00479-0","volume":"13","author":"\u00c1 Lima","year":"2022","unstructured":"Lima \u00c1, Sousa H, Medeiros R, Nobre A, Machado M (2022) PD-L1 expression in EBV associated gastric cancer: a systematic review and meta-analysis. Discov Oncol 13(1):19. https:\/\/doi.org\/10.1007\/s12672-022-00479-0","journal-title":"Discov Oncol"},{"issue":"2","key":"297_CR114","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.molcel.2016.08.029","volume":"64","author":"M Lin","year":"2016","unstructured":"Lin M, Zhao Z, Yang Z, Meng Q, Tan P, Xie W et al (2016) USP38 inhibits type i interferon signaling by editing TBK1 ubiquitination through NLRP4 signalosome. Mol Cell 64(2):267\u2013281. https:\/\/doi.org\/10.1016\/j.molcel.2016.08.029","journal-title":"Mol Cell"},{"issue":"2","key":"297_CR115","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s0042-6822(03)00145-4","volume":"310","author":"P Liu","year":"2003","unstructured":"Liu P, Speck SH (2003) Synergistic autoactivation of the Epstein-Barr virus immediate-early BRLF1 promoter by Rta and Zta. Virology 310(2):199\u2013206. https:\/\/doi.org\/10.1016\/s0042-6822(03)00145-4","journal-title":"Virology"},{"issue":"8","key":"297_CR116","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.cellbi.2008.03.022","volume":"32","author":"SF Liu","year":"2008","unstructured":"Liu SF, Wang H, Lin XC, Xiang H, Deng XY, Li W et al (2008) NF-kappaB inhibitors induce lytic cytotoxicity in Epstein-Barr virus-positive nasopharyngeal carcinoma cells. Cell Biol Int 32(8):1006\u20131013. https:\/\/doi.org\/10.1016\/j.cellbi.2008.03.022","journal-title":"Cell Biol Int"},{"issue":"3","key":"297_CR117","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/ije\/dyv038","volume":"45","author":"Z Liu","year":"2016","unstructured":"Liu Z, Fang F, Chang ET, Adami HO, Ye W (2016) Sibship size, birth order and risk of nasopharyngeal carcinoma and infectious mononucleosis: a nationwide study in Sweden. Int J Epidemiol 45(3):825\u2013834. https:\/\/doi.org\/10.1093\/ije\/dyv038","journal-title":"Int J Epidemiol"},{"key":"297_CR118","doi-asserted-by":"publisher","first-page":"1091571","DOI":"10.3389\/fped.2022.1091571","volume":"10","author":"L Liu","year":"2022","unstructured":"Liu L, Wang Y, Wang W, Ying W, Sun B, Wang X, Sun J (2022) Increased expression of the TLR7\/9 signaling pathways in chronic active EBV infection. Front Pediatr 10:1091571. https:\/\/doi.org\/10.3389\/fped.2022.1091571","journal-title":"Front Pediatr"},{"issue":"1","key":"297_CR119","doi-asserted-by":"publisher","DOI":"10.15252\/embr.202050714","volume":"22","author":"X Long","year":"2021","unstructured":"Long X, Yang J, Zhang X, Yang Z, Li Y, Wang F et al (2021) BRLF1 suppresses RNA Pol III-mediated RIG-I inflammasome activation in the early EBV lytic lifecycle. EMBO Rep 22(1):e50714. https:\/\/doi.org\/10.15252\/embr.202050714","journal-title":"EMBO Rep"},{"key":"297_CR120","doi-asserted-by":"publisher","first-page":"1176724","DOI":"10.3389\/fimmu.2023.1176724","volume":"14","author":"A Look","year":"2023","unstructured":"Look A, Burns D, Tews I, Roghanian A, Mansour S (2023) Towards a better understanding of human iNKT cell subpopulations for improved clinical outcomes. Front Immunol 14:1176724. https:\/\/doi.org\/10.3389\/fimmu.2023.1176724","journal-title":"Front Immunol"},{"issue":"6","key":"297_CR121","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1159\/000479749","volume":"9","author":"Y Lu","year":"2017","unstructured":"Lu Y, Qin Z, Wang J, Zheng X, Lu J, Zhang X et al (2017) Epstein-Barr virus miR-BART6-3p Inhibits the RIG-I Pathway. J Innate Immun 9(6):574\u2013586. https:\/\/doi.org\/10.1159\/000479749","journal-title":"J Innate Immun"},{"issue":"2","key":"297_CR122","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1011186","volume":"19","author":"WY Lui","year":"2023","unstructured":"Lui WY, Bharti A, Wong NM, Jangra S, Botelho MG, Yuen KS, Jin DY (2023) Suppression of cGAS- and RIG-I-mediated innate immune signaling by Epstein-Barr virus deubiquitinase BPLF1. PLoS Pathog 19(2):e1011186. https:\/\/doi.org\/10.1371\/journal.ppat.1011186","journal-title":"PLoS Pathog"},{"issue":"10","key":"297_CR123","doi-asserted-by":"publisher","first-page":"4989","DOI":"10.4049\/jimmunol.1301046","volume":"191","author":"A L\u00fcnemann","year":"2013","unstructured":"L\u00fcnemann A, Vanoaica LD, Azzi T, Nadal D, M\u00fcnz C (2013) A distinct subpopulation of human NK cells restricts B cell transformation by EBV. J Immunol 191(10):4989\u20134995. https:\/\/doi.org\/10.4049\/jimmunol.1301046","journal-title":"J Immunol"},{"key":"297_CR124","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/978-3-319-22834-1_9","volume":"391","author":"A L\u00fcnemann","year":"2015","unstructured":"L\u00fcnemann A, Rowe M, Nadal D (2015) Innate immune recognition of EBV. Curr Top Microbiol Immunol 391:265\u2013287. https:\/\/doi.org\/10.1007\/978-3-319-22834-1_9","journal-title":"Curr Top Microbiol Immunol"},{"issue":"5","key":"297_CR125","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005642","volume":"12","author":"SD Ma","year":"2016","unstructured":"Ma SD, Xu X, Jones R, Delecluse HJ, Zumwalde NA, Sharma A et al (2016) PD-1\/CTLA-4 blockade inhibits Epstein-Barr virus-induced lymphoma growth in a cord blood humanized-mouse model. PLoS Pathog 12(5):e1005642. https:\/\/doi.org\/10.1371\/journal.ppat.1005642","journal-title":"PLoS Pathog"},{"issue":"1","key":"297_CR126","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/imr.12725","volume":"287","author":"EM Mace","year":"2019","unstructured":"Mace EM, Orange JS (2019) Emerging insights into human health and NK cell biology from the study of NK cell deficiencies. Immunol Rev 287(1):202\u2013225. https:\/\/doi.org\/10.1111\/imr.12725","journal-title":"Immunol Rev"},{"issue":"6","key":"297_CR127","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1111\/j.1365-2141.2011.09013.x","volume":"156","author":"I Magrath","year":"2012","unstructured":"Magrath I (2012) Epidemiology: clues to the pathogenesis of Burkitt lymphoma. Br J Haematol 156(6):744\u2013756. https:\/\/doi.org\/10.1111\/j.1365-2141.2011.09013.x","journal-title":"Br J Haematol"},{"issue":"6","key":"297_CR128","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1089\/jir.2018.0155","volume":"39","author":"G Mahesh","year":"2019","unstructured":"Mahesh G, Biswas R (2019) MicroRNA-155: a master regulator of inflammation. J Interf Cytokine Res 39(6):321\u2013330. https:\/\/doi.org\/10.1089\/jir.2018.0155","journal-title":"J Interf Cytokine Res"},{"issue":"8","key":"297_CR129","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1038\/sj.onc.1206184","volume":"22","author":"S Majumdar","year":"2003","unstructured":"Majumdar S, Aggarwal BB (2003) Adenosine suppresses activation of nuclear factor-kappaB selectively induced by tumor necrosis factor in different cell types. Oncogene 22(8):1206\u20131218. https:\/\/doi.org\/10.1038\/sj.onc.1206184","journal-title":"Oncogene"},{"issue":"18","key":"297_CR130","doi-asserted-by":"publisher","first-page":"9748","DOI":"10.1128\/jvi.01122-07","volume":"81","author":"HJ Martin","year":"2007","unstructured":"Martin HJ, Lee JM, Walls D, Hayward SD (2007) Manipulation of the toll-like receptor 7 signaling pathway by Epstein-Barr virus. J Virol 81(18):9748\u20139758. https:\/\/doi.org\/10.1128\/jvi.01122-07","journal-title":"J Virol"},{"issue":"5","key":"297_CR131","doi-asserted-by":"publisher","first-page":"1364","DOI":"10.1016\/s0006-291x(02)00380-7","volume":"293","author":"M Matsumoto","year":"2002","unstructured":"Matsumoto M, Kikkawa S, Kohase M, Miyake K, Seya T (2002) Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochem Biophys Res Commun 293(5):1364\u20131369. https:\/\/doi.org\/10.1016\/s0006-291x(02)00380-7","journal-title":"Biochem Biophys Res Commun"},{"issue":"3","key":"297_CR132","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3390\/vaccines3030703","volume":"3","author":"JC Mbongue","year":"2015","unstructured":"Mbongue JC, Nicholas DA, Torrez TW, Kim NS, Firek AF, Langridge WH (2015) The role of indoleamine 2, 3-dioxygenase in immune suppression and autoimmunity. Vaccines (Basel) 3(3):703\u2013729. https:\/\/doi.org\/10.3390\/vaccines3030703","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"297_CR133","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1038\/s41467-022-29307-3","volume":"13","author":"AJ Mentzer","year":"2022","unstructured":"Mentzer AJ, Brenner N, Allen N, Littlejohns TJ, Chong AY, Cortes A et al (2022) Identification of host-pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank. Nat Commun 13(1):1818. https:\/\/doi.org\/10.1038\/s41467-022-29307-3","journal-title":"Nat Commun"},{"issue":"7","key":"297_CR134","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0011908","volume":"5","author":"F Michaud","year":"2010","unstructured":"Michaud F, Coulombe F, Gaudreault E, Paquet-Bouchard C, Rola-Pleszczynski M, Gosselin J (2010) Epstein-Barr virus interferes with the amplification of IFNalpha secretion by activating suppressor of cytokine signaling 3 in primary human monocytes. PLoS One 5(7):e11908. https:\/\/doi.org\/10.1371\/journal.pone.0011908","journal-title":"PLoS One"},{"issue":"1","key":"297_CR135","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.pathol.2023.09.013","volume":"56","author":"S Midorikawa","year":"2024","unstructured":"Midorikawa S, Mizukami H, Kudoh K, Takeuchi Y, Sasaki T, Kushibiki H et al (2024) Diabetes can increase the prevalence of EBV infection and worsen the prognosis of nasopharyngeal carcinoma. Pathology 56(1):65\u201374. https:\/\/doi.org\/10.1016\/j.pathol.2023.09.013","journal-title":"Pathology"},{"issue":"1","key":"297_CR136","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/eji.200425524","volume":"35","author":"S Minguet","year":"2005","unstructured":"Minguet S, Huber M, Rosenkranz L, Schamel WW, Reth M, Brummer T (2005) Adenosine and cAMP are potent inhibitors of the NF-kappa B pathway downstream of immunoreceptors. Eur J Immunol 35(1):31\u201341. https:\/\/doi.org\/10.1002\/eji.200425524","journal-title":"Eur J Immunol"},{"issue":"12","key":"297_CR137","doi-asserted-by":"publisher","first-page":"5088","DOI":"10.1111\/cas.15152","volume":"112","author":"S Miyagi","year":"2021","unstructured":"Miyagi S, Watanabe T, Hara Y, Arata M, Uddin MK, Mantoku K et al (2021) A STING inhibitor suppresses EBV-induced B cell transformation and lymphomagenesis. Cancer Sci 112(12):5088\u20135099. https:\/\/doi.org\/10.1111\/cas.15152","journal-title":"Cancer Sci"},{"key":"297_CR138","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ijid.2020.09.1300","volume":"101","author":"A Moyano","year":"2020","unstructured":"Moyano A, Gerpe NMF, de Matteo E, Preciado MV, Chabay PA (2020) Macrophage\u2019s role in the microenvironmentgainst Epstein Barr Virus (EBV) in tonsils from pediatrics patients. Int J Infect Dis 101:499\u2013500. https:\/\/doi.org\/10.1016\/j.ijid.2020.09.1300","journal-title":"Int J Infect Dis"},{"issue":"1","key":"297_CR139","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01434-21","volume":"96","author":"A Moyano","year":"2022","unstructured":"Moyano A, Ferressini Gerpe NM, De Matteo E, Preciado MV, Chabay P (2022) M1 macrophage polarization prevails in Epstein-Barr virus-infected children in an immunoregulatory environment. J Virol 96(1):e0143421. https:\/\/doi.org\/10.1128\/jvi.01434-21","journal-title":"J Virol"},{"issue":"6704","key":"297_CR140","doi-asserted-by":"publisher","first-page":"eadk4898","DOI":"10.1126\/science.adk4898","volume":"385","author":"B M\u00fcller-Durovic","year":"2024","unstructured":"M\u00fcller-Durovic B, J\u00e4ger J, Engelmann C, Schuhmachers P, Altermatt S, Schlup Y et al (2024) A metabolic dependency of EBV can be targeted to hinder B cell transformation. Science 385(6704):eadk4898. https:\/\/doi.org\/10.1126\/science.adk4898","journal-title":"Science"},{"issue":"4","key":"297_CR141","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1002\/rmv.1786","volume":"24","author":"T Murata","year":"2014","unstructured":"Murata T, Sato Y, Kimura H (2014) Modes of infection and oncogenesis by the Epstein-Barr virus. Rev Med Virol 24(4):242\u2013253. https:\/\/doi.org\/10.1002\/rmv.1786","journal-title":"Rev Med Virol"},{"issue":"1","key":"297_CR142","doi-asserted-by":"publisher","first-page":"11343","DOI":"10.1038\/s41598-021-90596-7","volume":"11","author":"BM Muriuki","year":"2021","unstructured":"Muriuki BM, Forconi CS, Oluoch PO, Bailey JA, Ghansah A, Moormann AM, Ong\u2019echa, J. M. (2021) Association of killer cell immunoglobulin-like receptors with endemic Burkitt lymphoma in Kenyan children. Sci Rep 11(1):11343. https:\/\/doi.org\/10.1038\/s41598-021-90596-7","journal-title":"Sci Rep"},{"issue":"11","key":"297_CR143","doi-asserted-by":"publisher","first-page":"5998","DOI":"10.4049\/jimmunol.164.11.5998","volume":"164","author":"M Muzio","year":"2000","unstructured":"Muzio M, Bosisio D, Polentarutti N, D\u2019Amico G, Stoppacciaro A, Mancinelli R et al (2000) Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164(11):5998\u20136004. https:\/\/doi.org\/10.4049\/jimmunol.164.11.5998","journal-title":"J Immunol"},{"issue":"4","key":"297_CR144","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1016\/j.chom.2009.03.003","volume":"5","author":"D Nachmani","year":"2009","unstructured":"Nachmani D, Stern-Ginossar N, Sarid R, Mandelboim O (2009) Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells. Cell Host Microbe 5(4):376\u2013385. https:\/\/doi.org\/10.1016\/j.chom.2009.03.003","journal-title":"Cell Host Microbe"},{"issue":"6","key":"297_CR145","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/j.it.2023.04.002","volume":"44","author":"L Naesens","year":"2023","unstructured":"Naesens L, Haerynck F, Gack MU (2023) The RNA polymerase III-RIG-I axis in antiviral immunity and inflammation. Trends Immunol 44(6):435\u2013449. https:\/\/doi.org\/10.1016\/j.it.2023.04.002","journal-title":"Trends Immunol"},{"issue":"5","key":"297_CR146","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1128\/jvi.61.5.1416-1420.1987","volume":"61","author":"GR Nemerow","year":"1987","unstructured":"Nemerow GR, Mold C, Schwend VK, Tollefson V, Cooper NR (1987) Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV\/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d. J Virol 61(5):1416\u20131420. https:\/\/doi.org\/10.1128\/jvi.61.5.1416-1420.1987","journal-title":"J Virol"},{"key":"297_CR147","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.827921","volume":"13","author":"M Niu","year":"2022","unstructured":"Niu M, Liu Y, Yi M, Jiao D, Wu K (2022) Biological characteristics and clinical significance of soluble PD-1\/PD-L1 and exosomal PD-L1 in cancer. Front Immunol 13:827921. https:\/\/doi.org\/10.3389\/fimmu.2022.827921","journal-title":"Front Immunol"},{"issue":"5","key":"297_CR148","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1182\/blood-2008-02-136325","volume":"112","author":"SV Novitskiy","year":"2008","unstructured":"Novitskiy SV, Ryzhov S, Zaynagetdinov R, Goldstein AE, Huang Y, Tikhomirov OY et al (2008) Adenosine receptors in regulation of dendritic cell differentiation and function. Blood 112(5):1822\u20131831. https:\/\/doi.org\/10.1182\/blood-2008-02-136325","journal-title":"Blood"},{"issue":"2","key":"297_CR149","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.celrep.2013.01.023","volume":"3","author":"JG Ogembo","year":"2013","unstructured":"Ogembo JG, Kannan L, Ghiran I, Nicholson-Weller A, Finberg RW, Tsokos GC, Fingeroth JD (2013) Human complement receptor type 1\/CD35 is an Epstein-Barr virus receptor. Cell Rep 3(2):371\u2013385. https:\/\/doi.org\/10.1016\/j.celrep.2013.01.023","journal-title":"Cell Rep"},{"issue":"1","key":"297_CR150","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1440-1827.1999.00816.x","volume":"49","author":"K Ohshima","year":"1999","unstructured":"Ohshima K, Suzumiya J, Sugihara M, Nagafuchi S, Ohga S, Kikuchi M (1999) CD95 (Fas) ligand expression of Epstein-Barr virus (EBV)-infected lymphocytes: a possible mechanism of immune evasion in chronic active EBV infection. Pathol Int 49(1):9\u201313. https:\/\/doi.org\/10.1046\/j.1440-1827.1999.00816.x","journal-title":"Pathol Int"},{"key":"297_CR151","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.3389\/fimmu.2017.01942","volume":"8","author":"M Okamoto","year":"2017","unstructured":"Okamoto M, Kouwaki T, Fukushima Y, Oshiumi H (2017) Regulation of RIG-I activation by K63-linked polyubiquitination. Front Immunol 8:1942. https:\/\/doi.org\/10.3389\/fimmu.2017.01942","journal-title":"Front Immunol"},{"key":"297_CR152","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.humpath.2017.10.029","volume":"71","author":"PK Panjwani","year":"2018","unstructured":"Panjwani PK, Charu V, DeLisser M, Molina-Kirsch H, Natkunam Y, Zhao S (2018) Programmed death-1 ligands PD-L1 and PD-L2 show distinctive and restricted patterns of expression in lymphoma subtypes. Hum Pathol 71:91\u201399. https:\/\/doi.org\/10.1016\/j.humpath.2017.10.029","journal-title":"Hum Pathol"},{"key":"297_CR1001","doi-asserted-by":"publisher","unstructured":"Panikkar A, Smith C, Hislop A, Tellam N, Dasari V, Hogquist KA, Wykes M, Moss DJ, Rickinson A, Balfour HH Jr, Khanna R (2015) Cytokine-Mediated Loss of Blood Dendritic Cells During Epstein-Barr Virus-Associated Acute Infectious Mononucleosis: Implication for Immune Dysregulation. J Infect Dis 212(12):1957\u201361. https:\/\/doi.org\/10.1093\/infdis\/jiv340","DOI":"10.1093\/infdis\/jiv340"},{"issue":"10","key":"297_CR153","doi-asserted-by":"publisher","first-page":"3985","DOI":"10.1182\/blood-2002-07-2113","volume":"101","author":"E Panther","year":"2003","unstructured":"Panther E, Corinti S, Idzko M, Herouy Y, Napp M, la Sala A et al (2003) Adenosine affects expression of membrane molecules, cytokine and chemokine release, and the T-cell stimulatory capacity of human dendritic cells. Blood 101(10):3985\u20133990. https:\/\/doi.org\/10.1182\/blood-2002-07-2113","journal-title":"Blood"},{"issue":"2","key":"297_CR154","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1128\/jvi.01777-06","volume":"81","author":"IY Pappworth","year":"2007","unstructured":"Pappworth IY, Wang EC, Rowe M (2007) The switch from latent to productive infection in epstein-barr virus-infected B cells is associated with sensitization to NK cell killing. J Virol 81(2):474\u2013482. https:\/\/doi.org\/10.1128\/jvi.01777-06","journal-title":"J Virol"},{"issue":"5","key":"297_CR155","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1084\/jem.20042432","volume":"201","author":"B Pasquier","year":"2005","unstructured":"Pasquier B, Yin L, Fondan\u00e8che MC, Relouzat F, Bloch-Queyrat C, Lambert N et al (2005) Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product. J Exp Med 201(5):695\u2013701. https:\/\/doi.org\/10.1084\/jem.20042432","journal-title":"J Exp Med"},{"issue":"9","key":"297_CR156","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1007\/s00277-015-2403-2","volume":"94","author":"S Paydas","year":"2015","unstructured":"Paydas S, Ba\u011f\u0131r E, Seydaoglu G, Ercolak V, Ergin M (2015) Programmed death-1 (PD-1), programmed death-ligand 1 (PD-L1), and EBV-encoded RNA (EBER) expression in Hodgkin lymphoma. Ann Hematol 94(9):1545\u20131552. https:\/\/doi.org\/10.1007\/s00277-015-2403-2","journal-title":"Ann Hematol"},{"issue":"1","key":"297_CR157","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12985-017-0891-5","volume":"14","author":"G Pisano","year":"2017","unstructured":"Pisano G, Roy A, Ahmed Ansari M, Kumar B, Chikoti L, Chandran B (2017) Interferon-\u03b3-inducible protein 16 (IFI16) is required for the maintenance of Epstein-Barr virus latency. Virol J 14(1):221. https:\/\/doi.org\/10.1186\/s12985-017-0891-5","journal-title":"Virol J"},{"issue":"4","key":"297_CR158","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1111\/j.1365-2567.2008.03027.x","volume":"126","author":"A Poli","year":"2009","unstructured":"Poli A, Michel T, Th\u00e9r\u00e9sine M, Andr\u00e8s E, Hentges F, Zimmer J (2009) CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 126(4):458\u2013465. https:\/\/doi.org\/10.1111\/j.1365-2567.2008.03027.x","journal-title":"Immunology"},{"issue":"1","key":"297_CR159","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1186\/s12885-019-5466-y","volume":"19","author":"L Qiu","year":"2019","unstructured":"Qiu L, Zheng H, Zhao X (2019) The prognostic and clinicopathological significance of PD-L1 expression in patients with diffuse large B-cell lymphoma: a meta-analysis. BMC Cancer 19(1):273. https:\/\/doi.org\/10.1186\/s12885-019-5466-y","journal-title":"BMC Cancer"},{"issue":"6","key":"297_CR160","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1002\/art.27408","volume":"62","author":"TE Quan","year":"2010","unstructured":"Quan TE, Roman RM, Rudenga BJ, Holers VM, Craft JE (2010) Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells. Arthritis Rheum 62(6):1693\u20131701. https:\/\/doi.org\/10.1002\/art.27408","journal-title":"Arthritis Rheum"},{"issue":"6","key":"297_CR161","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004906","volume":"11","author":"C Rancan","year":"2015","unstructured":"Rancan C, Schirrmann L, H\u00fcls C, Zeidler R, Moosmann A (2015) Latent membrane protein LMP2A impairs recognition of EBV-infected cells by CD8+ T Cells. PLoS Pathog 11(6):e1004906. https:\/\/doi.org\/10.1371\/journal.ppat.1004906","journal-title":"PLoS Pathog"},{"issue":"1\u20133","key":"297_CR162","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1385\/ir:36:1:91","volume":"36","author":"T Raskovalova","year":"2006","unstructured":"Raskovalova T, Lokshin A, Huang X, Jackson EK, Gorelik E (2006) Adenosine-mediated inhibition of cytotoxic activity and cytokine production by IL-2\/NKp46-activated NK cells: involvement of protein kinase A isozyme I (PKA I). Immunol Res 36(1\u20133):91\u201399. https:\/\/doi.org\/10.1385\/ir:36:1:91","journal-title":"Immunol Res"},{"issue":"7115","key":"297_CR163","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/nature05257","volume":"444","author":"S Rigaud","year":"2006","unstructured":"Rigaud S, Fondan\u00e8che MC, Lambert N, Pasquier B, Mateo V, Soulas P et al (2006) XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome. Nature 444(7115):110\u2013114. https:\/\/doi.org\/10.1038\/nature05257","journal-title":"Nature"},{"issue":"5","key":"297_CR164","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.4049\/jimmunol.160.5.2442","volume":"160","author":"CJ Roberge","year":"1998","unstructured":"Roberge CJ, McColl SR, Larochelle B, Gosselin J (1998) Granulocyte-macrophage colony-stimulating factor enhances EBV-induced synthesis of chemotactic factors in human neutrophils. J Immunol 160(5):2442\u20132448","journal-title":"J Immunol"},{"issue":"11","key":"297_CR165","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1038\/s41584-024-01167-9","volume":"20","author":"WH Robinson","year":"2024","unstructured":"Robinson WH, Younis S, Love ZZ, Steinman L, Lanz TV (2024) Epstein-Barr virus as a potentiator of autoimmune diseases. Nat Rev Rheumatol 20(11):729\u2013740. https:\/\/doi.org\/10.1038\/s41584-024-01167-9","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"297_CR166","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1128\/jvi.63.7.3109-3116.1989","volume":"63","author":"CM Rooney","year":"1989","unstructured":"Rooney CM, Rowe DT, Ragot T, Farrell PJ (1989) The spliced BZLF1 gene of Epstein-Barr virus (EBV) transactivates an early EBV promoter and induces the virus productive cycle. J Virol 63(7):3109\u20133116. https:\/\/doi.org\/10.1128\/jvi.63.7.3109-3116.1989","journal-title":"J Virol"},{"issue":"9","key":"297_CR167","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1128\/mcb.1.9.785-796.1981","volume":"1","author":"MD Rosa","year":"1981","unstructured":"Rosa MD, Gottlieb E, Lerner MR, Steitz JA (1981) Striking similarities are exhibited by two small Epstein-Barr virus-encoded ribonucleic acids and the adenovirus-associated ribonucleic acids VAI and VAII. Mol Cell Biol 1(9):785\u2013796. https:\/\/doi.org\/10.1128\/mcb.1.9.785-796.1981","journal-title":"Mol Cell Biol"},{"issue":"3","key":"297_CR168","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2020.100937","volume":"23","author":"N Roy Chattopadhyay","year":"2020","unstructured":"Roy Chattopadhyay N, Chatterjee K, Tiwari N, Chakrabarti S, Sahu SK, Deb Roy S et al (2020) TLR9 polymorphisms might contribute to the ethnicity bias for EBV-infected nasopharyngeal carcinoma. iScience 23(3):100937. https:\/\/doi.org\/10.1016\/j.isci.2020.100937","journal-title":"iScience"},{"key":"297_CR169","doi-asserted-by":"publisher","unstructured":"Roy A, Ghosh A, Kumar B, Chandran B (2019) IFI16, a nuclear innate immune DNA sensor, mediates epigenetic silencing of herpesvirus genomes by its association with H3K9 methyltransferases SUV39H1 and GLP. elife 8. https:\/\/doi.org\/10.7554\/eLife.49500","DOI":"10.7554\/eLife.49500"},{"issue":"1","key":"297_CR170","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1186\/s12885-019-5816-9","volume":"19","author":"M Ruuskanen","year":"2019","unstructured":"Ruuskanen M, Leivo I, Minn H, Vahlberg T, Haglund C, Hagstr\u00f6m J, Irjala H (2019) Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma. BMC Cancer 19(1):624. https:\/\/doi.org\/10.1186\/s12885-019-5816-9","journal-title":"BMC Cancer"},{"issue":"1","key":"297_CR171","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1128\/jvi.32.1.8-18.1979","volume":"32","author":"L Rymo","year":"1979","unstructured":"Rymo L (1979) Identification of transcribed regions of Epstein-Barr virus DNA in Burkitt lymphoma-derived cells. J Virol 32(1):8\u201318. https:\/\/doi.org\/10.1128\/jvi.32.1.8-18.1979","journal-title":"J Virol"},{"issue":"7","key":"297_CR172","doi-asserted-by":"publisher","first-page":"4060","DOI":"10.1128\/jvi.02020-12","volume":"87","author":"S Saito","year":"2013","unstructured":"Saito S, Murata T, Kanda T, Isomura H, Narita Y, Sugimoto A et al (2013) Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-\u03baB signaling during productive replication. J Virol 87(7):4060\u20134070. https:\/\/doi.org\/10.1128\/jvi.02020-12","journal-title":"J Virol"},{"issue":"1","key":"297_CR173","doi-asserted-by":"publisher","first-page":"321","DOI":"10.4049\/jimmunol.173.1.321","volume":"173","author":"S Salek-Ardakani","year":"2004","unstructured":"Salek-Ardakani S, Lyons SA, Arrand JR (2004) Epstein-Barr virus promotes human monocyte survival and maturation through a paracrine induction of IFN-alpha. J Immunol 173(1):321\u2013331. https:\/\/doi.org\/10.4049\/jimmunol.173.1.321","journal-title":"J Immunol"},{"issue":"18","key":"297_CR174","doi-asserted-by":"publisher","first-page":"4207-4214-4214","DOI":"10.1038\/sj.emboj.7601314","volume":"25","author":"M Samanta","year":"2006","unstructured":"Samanta M, Iwakiri D, Kanda T, Imaizumi T, Takada K (2006) EB virus-encoded RNAs are recognized by RIG-I and activate signaling to induce type I IFN. EMBO J 25(18):4207-4214-4214. https:\/\/doi.org\/10.1038\/sj.emboj.7601314","journal-title":"EMBO J"},{"issue":"5","key":"297_CR175","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1172\/jci24041","volume":"115","author":"DJ Sanchez","year":"2005","unstructured":"Sanchez DJ, Gumperz JE, Ganem D (2005) Regulation of CD1d expression and function by a herpesvirus infection. J Clin Invest 115(5):1369\u20131378. https:\/\/doi.org\/10.1172\/jci24041","journal-title":"J Clin Invest"},{"issue":"1","key":"297_CR176","doi-asserted-by":"publisher","first-page":"13557","DOI":"10.1038\/ncomms13557","volume":"7","author":"K Sathiyamoorthy","year":"2016","unstructured":"Sathiyamoorthy K, Hu YX, M\u00f6hl BS, Chen J, Longnecker R, Jardetzky TS (2016) Structural basis for Epstein\u2013Barr virus host cell tropism mediated by gp42 and gHgL entry glycoproteins. Nat Commun 7(1):13557. https:\/\/doi.org\/10.1038\/ncomms13557","journal-title":"Nat Commun"},{"issue":"6","key":"297_CR177","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1128\/jvi.74.6.2612-2619.2000","volume":"74","author":"M Savard","year":"2000","unstructured":"Savard M, B\u00e9langer C, Tardif M, Gourde P, Flamand L, Gosselin J (2000) Infection of primary human monocytes by Epstein-Barr virus. J Virol 74(6):2612\u20132619. https:\/\/doi.org\/10.1128\/jvi.74.6.2612-2619.2000","journal-title":"J Virol"},{"issue":"21","key":"297_CR178","doi-asserted-by":"publisher","first-page":"10292","DOI":"10.1073\/pnas.89.21.10292","volume":"89","author":"M Schwemmle","year":"1992","unstructured":"Schwemmle M, Clemens MJ, Hilse K, Pfeifer K, Tr\u00f6ster H, M\u00fcller WE, Bachmann M (1992) Localization of Epstein-Barr virus-encoded RNAs EBER-1 and EBER-2 in interphase and mitotic Burkitt lymphoma cells. Proc Natl Acad Sci 89(21):10292\u201310296. https:\/\/doi.org\/10.1073\/pnas.89.21.10292","journal-title":"Proc Natl Acad Sci"},{"key":"297_CR179","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3389\/fimmu.2017.00360","volume":"8","author":"SD Scoville","year":"2017","unstructured":"Scoville SD, Freud AG, Caligiuri MA (2017) Modeling human natural killer cell development in the era of innate lymphoid cells. Front Immunol 8:360. https:\/\/doi.org\/10.3389\/fimmu.2017.00360","journal-title":"Front Immunol"},{"key":"297_CR180","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.coviro.2013.12.001","volume":"4","author":"C Shannon-Lowe","year":"2014","unstructured":"Shannon-Lowe C, Rowe M (2014) Epstein Barr virus entry; kissing and conjugation. Curr Opin Virol 4:78\u201384. https:\/\/doi.org\/10.1016\/j.coviro.2013.12.001","journal-title":"Curr Opin Virol"},{"key":"297_CR181","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.canep.2019.05.003","volume":"61","author":"U Sharma","year":"2019","unstructured":"Sharma U, Singhal P, Bandil K, Patle R, Kumar A, Neyaz K et al (2019) Genetic variations of TLRs and their association with HPV\/EBV, co-infection along with nicotine exposure in the development of premalignant\/malignant lesions of the oral cavity in Indian population. Cancer Epidemiol 61:38\u201349. https:\/\/doi.org\/10.1016\/j.canep.2019.05.003","journal-title":"Cancer Epidemiol"},{"key":"297_CR182","doi-asserted-by":"publisher","unstructured":"Shechter O, Sausen DG, Gallo ES, Dahari H, Borenstein R (2022) Epstein-Barr Virus (EBV) epithelial associated malignancies: exploring pathologies and current treatments. Int J Mol Sci 23(22). https:\/\/doi.org\/10.3390\/ijms232214389","DOI":"10.3390\/ijms232214389"},{"issue":"1","key":"297_CR183","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s007050050492","volume":"144","author":"M Shimakage","year":"1999","unstructured":"Shimakage M, Kimura M, Yanoma S, Ibe M, Yokota S, Tsujino G et al (1999) Expression of latent and replicative-infection genes of Epstein-Barr virus in macrophage. Arch Virol 144(1):157\u2013166. https:\/\/doi.org\/10.1007\/s007050050492","journal-title":"Arch Virol"},{"issue":"2","key":"297_CR184","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1182\/blood.2020008640","volume":"137","author":"D Sinha","year":"2021","unstructured":"Sinha D, Khanna R (2021) EBV and myeloid-derived suppressor cells. Blood 137(2):148\u2013150. https:\/\/doi.org\/10.1182\/blood.2020008640","journal-title":"Blood"},{"key":"297_CR1000","doi-asserted-by":"publisher","unstructured":"Skinner CM, Ivanov NS, Barr SA, Chen Y, Skalsky RL (2017) An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1. J Virol 91(21):e00530-17. https:\/\/doi.org\/10.1128\/JVI.00530-17","DOI":"10.1128\/JVI.00530-17"},{"key":"297_CR185","doi-asserted-by":"publisher","unstructured":"Smith NA, Coleman CB, Gewurz BE, Rochford R (2020) CD21 (complement receptor 2) is the receptor for Epstein-Barr virus entry into T cells. J Virol 94(11). https:\/\/doi.org\/10.1128\/jvi.00428-20","DOI":"10.1128\/jvi.00428-20"},{"issue":"12","key":"297_CR186","doi-asserted-by":"publisher","first-page":"1749","DOI":"10.1086\/523813","volume":"196","author":"EM Sokal","year":"2007","unstructured":"Sokal EM, Hoppenbrouwers K, Vandermeulen C, Moutschen M, L\u00e9onard P, Moreels A et al (2007) Recombinant gp350 vaccine for infectious mononucleosis: a phase 2, randomized, double- blind, placebo-controlled trial to evaluate the safety, immunogenicity, and efficacy of an Epstein- barr virus vaccine in healthy young adults. J Infect Dis 196(12):1749\u20131753. https:\/\/doi.org\/10.1086\/523813","journal-title":"J Infect Dis"},{"key":"297_CR187","doi-asserted-by":"publisher","unstructured":"St\u0119pie\u0144 E, Strycharz-Dudziak M, Malm M, Drop B, Polz-Dacewicz M (2021) Serum and tissue level of TLR9 in EBV-associated oropharyngeal cancer. Cancers (Basel) 13(16). https:\/\/doi.org\/10.3390\/cancers13163981","DOI":"10.3390\/cancers13163981"},{"issue":"2","key":"297_CR188","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0040027","volume":"4","author":"T Strowig","year":"2008","unstructured":"Strowig T, Brilot F, Arrey F, Bougras G, Thomas D, Muller WA, M\u00fcnz C (2008) Tonsilar NK cells restrict B cell transformation by the Epstein-Barr virus via IFN-gamma. PLoS Pathog 4(2):e27. https:\/\/doi.org\/10.1371\/journal.ppat.0040027","journal-title":"PLoS Pathog"},{"issue":"6","key":"297_CR189","doi-asserted-by":"publisher","first-page":"875","DOI":"10.5009\/gnl210359","volume":"16","author":"Q Sun","year":"2022","unstructured":"Sun Q, Fu Y, Chen X, Li L, Wu H, Liu Y et al (2022) Prognostic perspectives of STING and PD-L1 expression and correlation with the prognosis of Epstein-Barr virus-associated gastric cancers. Gut Liver 16(6):875\u2013891. https:\/\/doi.org\/10.5009\/gnl210359","journal-title":"Gut Liver"},{"issue":"10","key":"297_CR190","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1073\/pnas.0400525101","volume":"101","author":"K Tabeta","year":"2004","unstructured":"Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, Crozat K et al (2004) Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci USA 101(10):3516\u20133521. https:\/\/doi.org\/10.1073\/pnas.0400525101","journal-title":"Proc Natl Acad Sci USA"},{"key":"297_CR191","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ceb.2019.02.002","volume":"59","author":"T Taguchi","year":"2019","unstructured":"Taguchi T, Mukai K (2019) Innate immunity signalling and membrane trafficking. Curr Opin Cell Biol 59:1\u20137. https:\/\/doi.org\/10.1016\/j.ceb.2019.02.002","journal-title":"Curr Opin Cell Biol"},{"issue":"3","key":"297_CR192","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1128\/jvi.57.3.1016-1022.1986","volume":"57","author":"K Takada","year":"1986","unstructured":"Takada K, Shimizu N, Sakuma S, Ono Y (1986) trans activation of the latent Epstein-Barr virus (EBV) genome after transfection of the EBV DNA fragment. J Virol 57(3):1016\u20131022. https:\/\/doi.org\/10.1128\/jvi.57.3.1016-1022.1986","journal-title":"J Virol"},{"issue":"7","key":"297_CR193","doi-asserted-by":"publisher","first-page":"3555","DOI":"10.4049\/jimmunol.167.7.3555","volume":"167","author":"F Takeshita","year":"2001","unstructured":"Takeshita F, Leifer CA, Gursel I, Ishii KJ, Takeshita S, Gursel M, Klinman DM (2001) Cutting edge: role of Toll-like receptor 9 in CpG DNA-induced activation of human cells. J Immunol 167(7):3555\u20133558. https:\/\/doi.org\/10.4049\/jimmunol.167.7.3555","journal-title":"J Immunol"},{"key":"297_CR194","doi-asserted-by":"publisher","unstructured":"Tan GW, Visser L, Tan LP, van den Berg A, Diepstra A (2018) The microenvironment in Epstein-Barr virus-associated malignancies. Pathogens 7(2). https:\/\/doi.org\/10.3390\/pathogens7020040","DOI":"10.3390\/pathogens7020040"},{"issue":"3","key":"297_CR195","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1158\/1078-0432.ccr-0670-3","volume":"10","author":"MP Thompson","year":"2004","unstructured":"Thompson MP, Kurzrock R (2004) Epstein-Barr virus and cancer. Clin Cancer Res 10(3):803\u2013821. https:\/\/doi.org\/10.1158\/1078-0432.ccr-0670-3","journal-title":"Clin Cancer Res"},{"issue":"11","key":"297_CR196","doi-asserted-by":"crossref","first-page":"3802","DOI":"10.4049\/jimmunol.139.11.3802","volume":"139","author":"BE Tomkinson","year":"1987","unstructured":"Tomkinson BE, Wagner DK, Nelson DL, Sullivan JL (1987) Activated lymphocytes during acute Epstein-Barr virus infection. J Immunol 139(11):3802\u20133807","journal-title":"J Immunol"},{"issue":"4","key":"297_CR197","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175053","volume":"12","author":"Y Torii","year":"2017","unstructured":"Torii Y, Kawada JI, Murata T, Yoshiyama H, Kimura H, Ito Y (2017) Epstein-Barr virus infection-induced inflammasome activation in human monocytes. PLoS One 12(4):e0175053. https:\/\/doi.org\/10.1371\/journal.pone.0175053","journal-title":"PLoS One"},{"issue":"6","key":"297_CR198","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1007\/bf00218044","volume":"36","author":"JA Trapani","year":"1992","unstructured":"Trapani JA, Browne KA, Dawson MJ, Ramsay RG, Eddy RL, Show TB et al (1992) A novel gene constitutively expressed in human lymphoid cells is inducible with interferon-gamma in myeloid cells. Immunogenetics 36(6):369\u2013376. https:\/\/doi.org\/10.1007\/bf00218044","journal-title":"Immunogenetics"},{"issue":"8","key":"297_CR199","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1002\/eji.1830180823","volume":"18","author":"CD Tsoukas","year":"1988","unstructured":"Tsoukas CD, Lambris JD (1988) Expression of CR2\/EBV receptors on human thymocytes detected by monoclonal antibodies. Eur J Immunol 18(8):1299\u20131302. https:\/\/doi.org\/10.1002\/eji.1830180823","journal-title":"Eur J Immunol"},{"issue":"11","key":"297_CR200","doi-asserted-by":"publisher","first-page":"5484","DOI":"10.1128\/jvi.00171-07","volume":"81","author":"S Tugizov","year":"2007","unstructured":"Tugizov S, Herrera R, Veluppillai P, Greenspan J, Greenspan D, Palefsky JM (2007) Epstein-Barr virus (EBV)-infected monocytes facilitate dissemination of EBV within the oral mucosal epithelium. J Virol 81(11):5484\u20135496. https:\/\/doi.org\/10.1128\/jvi.00171-07","journal-title":"J Virol"},{"issue":"8","key":"297_CR201","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0043317","volume":"7","author":"RM Valente","year":"2012","unstructured":"Valente RM, Ehlers E, Xu D, Ahmad H, Steadman A, Blasnitz L et al (2012) Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1. PLoS One 7(8):e43317. https:\/\/doi.org\/10.1371\/journal.pone.0043317","journal-title":"PLoS One"},{"issue":"2","key":"297_CR202","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1093\/infdis\/jis335","volume":"206","author":"FL van de Veerdonk","year":"2012","unstructured":"van de Veerdonk FL, Wever PC, Hermans MH, Fijnheer R, Joosten LA, van der Meer JW et al (2012) IL-18 serum concentration is markedly elevated in acute EBV infection and can serve as a marker for disease severity. J Infect Dis 206(2):197\u2013201. https:\/\/doi.org\/10.1093\/infdis\/jis335","journal-title":"J Infect Dis"},{"issue":"3","key":"297_CR203","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.4049\/jimmunol.0903120","volume":"186","author":"M van Gent","year":"2011","unstructured":"van Gent M, Griffin BD, Berkhoff EG, van Leeuwen D, Boer IG, Buisson M et al (2011) EBV lytic-phase protein BGLF5 contributes to TLR9 downregulation during productive infection. J Immunol 186(3):1694\u20131702. https:\/\/doi.org\/10.4049\/jimmunol.0903120","journal-title":"J Immunol"},{"issue":"Pt 4","key":"297_CR204","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1099\/jgv.0.000021","volume":"96","author":"M van Gent","year":"2015","unstructured":"van Gent M, Gram AM, Boer IGJ, Geerdink RJ, Lindenbergh MFS, Lebbink RJ et al (2015) Silencing the shutoff protein of Epstein-Barr virus in productively infected B cells points to (innate) targets for immune evasion. J Gen Virol 96(Pt 4):858\u2013865. https:\/\/doi.org\/10.1099\/jgv.0.000021","journal-title":"J Gen Virol"},{"issue":"1","key":"297_CR205","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/1750-9378-7-36","volume":"7","author":"B V\u00e9rillaud","year":"2012","unstructured":"V\u00e9rillaud B, Gressette M, Morel Y, Paturel C, Herman P, Lo KW et al (2012) Toll-like receptor 3 in Epstein-Barr virus-associated nasopharyngeal carcinomas: consistent expression and cytotoxic effects of its synthetic ligand poly(A:U) combined to a Smac-mimetic. Infect Agent Cancer 7(1):36. https:\/\/doi.org\/10.1186\/1750-9378-7-36","journal-title":"Infect Agent Cancer"},{"key":"297_CR206","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1146\/annurev-immunol-031210-101324","volume":"29","author":"MD Vesely","year":"2011","unstructured":"Vesely MD, Kershaw MH, Schreiber RD, Smyth MJ (2011) Natural innate and adaptive immunity to cancer. Annu Rev Immunol 29:235\u2013271. https:\/\/doi.org\/10.1146\/annurev-immunol-031210-101324","journal-title":"Annu Rev Immunol"},{"issue":"26","key":"297_CR207","doi-asserted-by":"publisher","first-page":"5705","DOI":"10.1016\/j.cell.2023.11.015","volume":"186","author":"H Vietzen","year":"2023","unstructured":"Vietzen H, Berger SM, K\u00fchner LM, Furlano PL, Bsteh G, Berger T et al (2023a) Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis. Cell 186(26):5705\u20135718.e5713. https:\/\/doi.org\/10.1016\/j.cell.2023.11.015","journal-title":"Cell"},{"key":"297_CR208","doi-asserted-by":"publisher","first-page":"1183788","DOI":"10.3389\/fimmu.2023.1183788","volume":"14","author":"H Vietzen","year":"2023","unstructured":"Vietzen H, Staber PB, Berger SM, Furlano PL, K\u00fchner LM, Lubowitzki S et al (2023b) Inhibitory NKG2A(+) and absent activating NKG2C(+) NK cell responses are associated with the development of EBV(+) lymphomas. Front Immunol 14:1183788. https:\/\/doi.org\/10.3389\/fimmu.2023.1183788","journal-title":"Front Immunol"},{"issue":"1","key":"297_CR209","doi-asserted-by":"publisher","first-page":"249","DOI":"10.4049\/jimmunol.166.1.249","volume":"166","author":"A Visintin","year":"2001","unstructured":"Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, Segal DM (2001) Regulation of Toll-like receptors in human monocytes and dendritic cells. J Immunol 166(1):249\u2013255. https:\/\/doi.org\/10.4049\/jimmunol.166.1.249","journal-title":"J Immunol"},{"issue":"2","key":"297_CR210","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.bbi.2007.07.007","volume":"22","author":"WJ Waldman","year":"2008","unstructured":"Waldman WJ, Williams MV Jr, Lemeshow S, Binkley P, Guttridge D, Kiecolt-Glaser JK et al (2008) Epstein-Barr virus-encoded dUTPase enhances proinflammatory cytokine production by macrophages in contact with endothelial cells: evidence for depression-induced atherosclerotic risk. Brain Behav Immun 22(2):215\u2013223. https:\/\/doi.org\/10.1016\/j.bbi.2007.07.007","journal-title":"Brain Behav Immun"},{"issue":"1","key":"297_CR211","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S1413-8670(12)70269-6","volume":"16","author":"JJ Wang","year":"2012","unstructured":"Wang JJ, Li YF, Jin YY, Wang X, Chen TX (2012) Effects of Epstein-Barr virus on the development of dendritic cells derived from cord blood monocytes: an essential role for apoptosis. Braz J Infect Dis 16(1):19\u201326","journal-title":"Braz J Infect Dis"},{"issue":"6","key":"297_CR212","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.immuni.2014.11.011","volume":"41","author":"Q Wang","year":"2014","unstructured":"Wang Q, Liu X, Cui Y, Tang Y, Chen W, Li S et al (2014a) The E3 ubiquitin ligase AMFR and INSIG1 bridge the activation of TBK1 kinase by modifying the adaptor STING. Immunity 41(6):919\u2013933. https:\/\/doi.org\/10.1016\/j.immuni.2014.11.011","journal-title":"Immunity"},{"issue":"1","key":"297_CR213","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.cellimm.2014.02.005","volume":"289","author":"X-F Wang","year":"2014","unstructured":"Wang X-F, Wang H-S, Wang H, Zhang F, Wang K-F, Guo Q et al (2014b) The role of indoleamine 2,3-dioxygenase (IDO) in immune tolerance: focus on macrophage polarization of THP-1 cells. Cell Immunol 289(1):42\u201348. https:\/\/doi.org\/10.1016\/j.cellimm.2014.02.005","journal-title":"Cell Immunol"},{"issue":"1","key":"297_CR214","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41467-022-28479-2","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Ge J, Wang Y, Xiong F, Guo J, Jiang X et al (2022a) EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1. Nat Commun 13(1):866. https:\/\/doi.org\/10.1038\/s41467-022-28479-2","journal-title":"Nat Commun"},{"key":"297_CR215","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.960852","volume":"13","author":"X Wang","year":"2022","unstructured":"Wang X, Xiong H, Ning Z (2022b) Implications of NKG2A in immunity and immune-mediated diseases. Front Immunol 13:960852. https:\/\/doi.org\/10.3389\/fimmu.2022.960852","journal-title":"Front Immunol"},{"issue":"24","key":"297_CR216","doi-asserted-by":"publisher","first-page":"7631","DOI":"10.1111\/febs.16206","volume":"289","author":"KW Wen","year":"2022","unstructured":"Wen KW, Wang L, Menke JR, Damania B (2022) Cancers associated with human gammaherpesviruses. FEBS J 289(24):7631\u20137669. https:\/\/doi.org\/10.1111\/febs.16206","journal-title":"FEBS J"},{"issue":"6","key":"297_CR217","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.02243-21","volume":"12","author":"D Westhoff Smith","year":"2021","unstructured":"Westhoff Smith D, Chakravorty A, Hayes M, Hammerschmidt W, Sugden B (2021) The Epstein-Barr virus oncogene EBNA1 suppresses natural killer cell responses and apoptosis early after infection of peripheral B Cells. mBio 12(6):e0224321. https:\/\/doi.org\/10.1128\/mBio.02243-21","journal-title":"mBio"},{"issue":"6","key":"297_CR218","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.02204-23","volume":"14","author":"KA Willard","year":"2023","unstructured":"Willard KA, Barry AP, Oduor CI, Ong\u2019echa JM, Bailey JA, Moormann AM, Luftig MA (2023) Viral and host factors drive a type 1 Epstein-Barr virus spontaneous lytic phenotype. MBio 14(6):e0220423. https:\/\/doi.org\/10.1128\/mbio.02204-23","journal-title":"MBio"},{"issue":"2","key":"297_CR219","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1111\/j.1365-2141.2005.05452.x","volume":"129","author":"H Williams","year":"2005","unstructured":"Williams H, McAulay K, Macsween KF, Gallacher NJ, Higgins CD, Harrison N et al (2005) The immune response to primary EBV infection: a role for natural killer cells. Br J Haematol 129(2):266\u2013274. https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05452.x","journal-title":"Br J Haematol"},{"issue":"2","key":"297_CR220","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1128\/jvi.01932-15","volume":"90","author":"LR Williams","year":"2016","unstructured":"Williams LR, Quinn LL, Rowe M, Zuo J (2016) Induction of the lytic cycle sensitizes Epstein-Barr virus-infected B cells to NK cell killing that is counteracted by virus-mediated NK cell evasion mechanisms in the late lytic cycle. J Virol 90(2):947\u2013958. https:\/\/doi.org\/10.1128\/jvi.01932-15","journal-title":"J Virol"},{"issue":"3","key":"297_CR221","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1002\/cncr.26309","volume":"118","author":"AM Wong","year":"2012","unstructured":"Wong AM, Kong KL, Tsang JW, Kwong DL, Guan XY (2012) Profiling of Epstein-Barr virus-encoded microRNAs in nasopharyngeal carcinoma reveals potential biomarkers and oncomirs. Cancer 118(3):698\u2013710. https:\/\/doi.org\/10.1002\/cncr.26309","journal-title":"Cancer"},{"issue":"3","key":"297_CR222","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/j.chom.2015.07.015","volume":"18","author":"JJ Wu","year":"2015","unstructured":"Wu JJ, Li W, Shao Y, Avey D, Fu B, Gillen J et al (2015) Inhibition of cGAS DNA sensing by a herpesvirus virion protein. Cell Host Microbe 18(3):333\u2013344. https:\/\/doi.org\/10.1016\/j.chom.2015.07.015","journal-title":"Cell Host Microbe"},{"issue":"1","key":"297_CR223","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1038\/s41467-017-00101-w","volume":"8","author":"J Xing","year":"2017","unstructured":"Xing J, Zhang A, Zhang H, Wang J, Li XC, Zeng MS, Zhang Z (2017) TRIM29 promotes DNA virus infections by inhibiting innate immune response. Nat Commun 8(1):945. https:\/\/doi.org\/10.1038\/s41467-017-00101-w","journal-title":"Nat Commun"},{"key":"297_CR224","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3389\/fimmu.2018.01446","volume":"9","author":"C Xu","year":"2018","unstructured":"Xu C, Sun L, Liu W, Duan Z (2018) Latent membrane protein 1 of Epstein-Barr Virus promotes RIG-I degradation mediated by proteasome pathway. Front Immunol 9:1446. https:\/\/doi.org\/10.3389\/fimmu.2018.01446","journal-title":"Front Immunol"},{"issue":"17","key":"297_CR225","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.01028-22","volume":"96","author":"H Xu","year":"2022","unstructured":"Xu H, Li X, Rousseau BA, Akinyemi IA, Frey TR, Zhou K et al (2022) IFI16 partners with KAP1 to maintain Epstein-Barr virus latency. J Virol 96(17):e0102822. https:\/\/doi.org\/10.1128\/jvi.01028-22","journal-title":"J Virol"},{"issue":"21","key":"297_CR226","doi-asserted-by":"publisher","first-page":"12765","DOI":"10.1128\/jvi.02037-14","volume":"88","author":"JS Ye","year":"2014","unstructured":"Ye JS, Kim N, Lee KJ, Nam YR, Lee U, Joo CH (2014) Lysine 63-linked TANK-binding kinase 1 ubiquitination by mindbomb E3 ubiquitin protein ligase 2 is mediated by the mitochondrial antiviral signaling protein. J Virol 88(21):12765\u201312776. https:\/\/doi.org\/10.1128\/jvi.02037-14","journal-title":"J Virol"},{"issue":"5638","key":"297_CR227","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1126\/science.1088902","volume":"301","author":"Y Yin","year":"2003","unstructured":"Yin Y, Manoury B, F\u00e5hraeus R (2003) Self-inhibition of synthesis and antigen presentation by Epstein-Barr virus-encoded EBNA1. Science 301(5638):1371\u20131374. https:\/\/doi.org\/10.1126\/science.1088902","journal-title":"Science"},{"issue":"3","key":"297_CR228","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2022.07.2092","volume":"114","author":"C Yixing","year":"2022","unstructured":"Yixing C, Xie F, Chen J, Dayu L, Li Z, Luo Q, Lin Q (2022) The LMP1\/Lgals1-NF-Kb-IRF1-PDL1 axis promotes immune escape in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 114(3):e514. https:\/\/doi.org\/10.1016\/j.ijrobp.2022.07.2092","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"297_CR229","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1007\/s10120-020-01059-3","volume":"23","author":"CJ Yoon","year":"2020","unstructured":"Yoon CJ, Chang MS, Kim DH, Kim W, Koo BK, Yun SC et al (2020) Epstein-Barr virus-encoded miR-BART5-5p upregulates PD-L1 through PIAS3\/pSTAT3 modulation, worsening clinical outcomes of PD-L1-positive gastric carcinomas. Gastric Cancer 23(5):780\u2013795. https:\/\/doi.org\/10.1007\/s10120-020-01059-3","journal-title":"Gastric Cancer"},{"issue":"9","key":"297_CR230","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1111\/j.1348-0421.2010.00248.x","volume":"54","author":"V Younesi","year":"2010","unstructured":"Younesi V, Nikzamir H, Yousefi M, Khoshnoodi J, Arjmand M, Rabbani H, Shokri F (2010) Epstein Barr virus inhibits the stimulatory effect of TLR7\/8 and TLR9 agonists but not CD40 ligand in human B lymphocytes. Microbiol Immunol 54(9):534\u2013541. https:\/\/doi.org\/10.1111\/j.1348-0421.2010.00248.x","journal-title":"Microbiol Immunol"},{"issue":"12","key":"297_CR231","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.it.2013.07.005","volume":"34","author":"J Yu","year":"2013","unstructured":"Yu J, Freud AG, Caligiuri MA (2013) Location and cellular stages of natural killer cell development. Trends Immunol 34(12):573\u2013582. https:\/\/doi.org\/10.1016\/j.it.2013.07.005","journal-title":"Trends Immunol"},{"issue":"8","key":"297_CR232","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1038\/ni1364","volume":"7","author":"W Yuan","year":"2006","unstructured":"Yuan W, Dasgupta A, Cresswell P (2006) Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nat Immunol 7(8):835\u2013842. https:\/\/doi.org\/10.1038\/ni1364","journal-title":"Nat Immunol"},{"issue":"20","key":"297_CR233","doi-asserted-by":"publisher","first-page":"7935","DOI":"10.1158\/0008-5472.Can-09-0828","volume":"69","author":"H Yuling","year":"2009","unstructured":"Yuling H, Ruijing X, Li L, Xiang J, Rui Z, Yujuan W et al (2009) EBV-induced human CD8+ NKT cells suppress tumorigenesis by EBV-associated malignancies. Cancer Res 69(20):7935\u20137944. https:\/\/doi.org\/10.1158\/0008-5472.Can-09-0828","journal-title":"Cancer Res"},{"issue":"32","key":"297_CR234","doi-asserted-by":"publisher","first-page":"4588","DOI":"10.1038\/onc.2010.203","volume":"29","author":"L Zauner","year":"2010","unstructured":"Zauner L, Melroe GT, Sigrist JA, Rechsteiner MP, Dorner M, Arnold M et al (2010) TLR9 triggering in Burkitt\u2019s lymphoma cell lines suppresses the EBV BZLF1 transcription via histone modification. Oncogene 29(32):4588\u20134598. https:\/\/doi.org\/10.1038\/onc.2010.203","journal-title":"Oncogene"},{"issue":"10","key":"297_CR235","doi-asserted-by":"publisher","first-page":"5748","DOI":"10.1128\/mcb.17.10.5748","volume":"17","author":"L Zhang","year":"1997","unstructured":"Zhang L, Pagano JS (1997) IRF-7, a new interferon regulatory factor associated with Epstein-Barr virus latency. Mol Cell Biol 17(10):5748\u20135757. https:\/\/doi.org\/10.1128\/mcb.17.10.5748","journal-title":"Mol Cell Biol"},{"issue":"1","key":"297_CR236","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1089\/107999002753452700","volume":"22","author":"L Zhang","year":"2002","unstructured":"Zhang L, Pagano JS (2002) Review: Structure and Function of IRF-7. J Interf Cytokine Res 22(1):95\u2013101. https:\/\/doi.org\/10.1089\/107999002753452700","journal-title":"J Interf Cytokine Res"},{"issue":"5844","key":"297_CR237","doi-asserted-by":"publisher","first-page":"1522","DOI":"10.1126\/science.1139522","volume":"317","author":"SY Zhang","year":"2007","unstructured":"Zhang SY, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P et al (2007a) TLR3 deficiency in patients with herpes simplex encephalitis. Science 317(5844):1522\u20131527. https:\/\/doi.org\/10.1126\/science.1139522","journal-title":"Science"},{"issue":"2","key":"297_CR238","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2567.2007.02573.x","volume":"121","author":"Y Zhang","year":"2007","unstructured":"Zhang Y, Wallace DL, de Lara CM, Ghattas H, Asquith B, Worth A et al (2007b) In vivo kinetics of human natural killer cells: the effects of ageing and acute and chronic viral infection. Immunology 121(2):258\u2013265. https:\/\/doi.org\/10.1111\/j.1365-2567.2007.02573.x","journal-title":"Immunology"},{"issue":"2","key":"297_CR239","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41564-017-0080-8","volume":"3","author":"H Zhang","year":"2018","unstructured":"Zhang H, Li Y, Wang HB, Zhang A, Chen ML, Fang ZX et al (2018) Ephrin receptor A2 is an epithelial cell receptor for Epstein-Barr virus entry. Nat Microbiol 3(2):1\u20138. https:\/\/doi.org\/10.1038\/s41564-017-0080-8","journal-title":"Nat Microbiol"},{"issue":"9","key":"297_CR240","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/s41419-020-02925-9","volume":"11","author":"B Zhang","year":"2020","unstructured":"Zhang B, Miao T, Shen X, Bao L, Zhang C, Yan C et al (2020) EB virus-induced ATR activation accelerates nasopharyngeal carcinoma growth via M2-type macrophages polarization. Cell Death Dis 11(9):742. https:\/\/doi.org\/10.1038\/s41419-020-02925-9","journal-title":"Cell Death Dis"},{"issue":"1","key":"297_CR241","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13000-022-01234-3","volume":"17","author":"WT Zhang","year":"2022","unstructured":"Zhang WT, Zhu GL, Xu WQ, Zhang W, Wang HZ, Wang YB, Li YX (2022) Association of PD-1\/PD-L1 expression and Epstein-Barr virus infection in patients with invasive breast cancer. Diagn Pathol 17(1):61. https:\/\/doi.org\/10.1186\/s13000-022-01234-3","journal-title":"Diagn Pathol"},{"key":"297_CR242","doi-asserted-by":"publisher","unstructured":"Zhang H, Sandhu PK, Damania B (2023) The role of RNA sensors in regulating innate immunity to gammaherpesviral infections. Cells 12(12). https:\/\/doi.org\/10.3390\/cells12121650","DOI":"10.3390\/cells12121650"},{"issue":"5","key":"297_CR243","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2024.107226","volume":"300","author":"X Zhang","year":"2024","unstructured":"Zhang X, Li Z, Peng Q, Liu C, Wu Y, Wen Y et al (2024) Epstein-Barr virus suppresses N(6)-methyladenosine modification of TLR9 to promote immune evasion. J Biol Chem 300(5):107226. https:\/\/doi.org\/10.1016\/j.jbc.2024.107226","journal-title":"J Biol Chem"},{"issue":"3","key":"297_CR244","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009459","volume":"5","author":"Y Zhao","year":"2010","unstructured":"Zhao Y, Xu D, Jiang Y, Zhang L (2010) Dual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytes. PLoS One 5(3):e9459. https:\/\/doi.org\/10.1371\/journal.pone.0009459","journal-title":"PLoS One"},{"issue":"4","key":"297_CR245","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1159\/000336178","volume":"4","author":"Y Zheng","year":"2012","unstructured":"Zheng Y, Zhang W, Ye Q, Zhou Y, Xiong W, He W et al (2012) Inhibition of Epstein-Barr virus infection by lactoferrin. J Innate Immun 4(4):387\u2013398. https:\/\/doi.org\/10.1159\/000336178","journal-title":"J Innate Immun"},{"issue":"11","key":"297_CR246","doi-asserted-by":"publisher","first-page":"1188","DOI":"10.1038\/labinvest.2014.105","volume":"94","author":"Y Zheng","year":"2014","unstructured":"Zheng Y, Qin Z, Ye Q, Chen P, Wang Z, Yan Q et al (2014) Lactoferrin suppresses the Epstein-Barr virus-induced inflammatory response by interfering with pattern recognition of TLR2 and TLR9. Lab Investig 94(11):1188\u20131199. https:\/\/doi.org\/10.1038\/labinvest.2014.105","journal-title":"Lab Investig"}],"container-title":["Current Topics in Microbiology and Immunology"],"original-title":[],"link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/82_2025_297","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T15:44:49Z","timestamp":1747842289000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/82_2025_297"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":248,"URL":"https:\/\/doi.org\/10.1007\/82_2025_297","relation":{},"ISSN":["0070-217X","2196-9965"],"issn-type":[{"value":"0070-217X","type":"print"},{"value":"2196-9965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"22 May 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}